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The	 microphthalmia	 family	 (MITF,	 TFEB,	 TFE3,	 and	 TFEC)	 of	transcription	 factors	 is	 emerging	 as	 global	 regulators	 of	 cancer	cell	survival	and	energy	metabolism,	both	through	the	promotion	of	 lysosomal	 genes	 as	 well	 as	 newly	 uncharacterized	 targets.	During	 my	 Ph.D.	 thesis	 project,	 I	 revealed	 a	 new	 set	 of	 TFEB	target	 genes	 that	 when	 activated	 could	 contribute	 to	 cell	migration	 and	 invasiveness	 in	 cancer.	During	my	work,	 I	 found	that	TFEB	regulates	 the	 filopodial	 initiator's	 factors	 IRSp53	and	EPS8	causing	a	change	in	cell	shape	and	an	increase	in	filopodia	number	 that	 correlates	 with	 an	 augmented	 motility	 and	invasiveness	of	 the	cell.	On	 the	contrary,	depletion	of	TFEB	and	TFE3	 leads	 to	 down-regulation	 of	 EPS8	 and	 IRSp53,	 and	 a	decrease	 of	 filopodia	 numbers.	 I	 confirmed	 the	 entire	 study	 in	the	Melanoma	cell	line	(501Mel),	a	model	of	cancer,	that	are	cells	with	a	high	degree	of	motility,	showing	that	also	 in	this	system,	there	is	an	increase	in	the	number	of	filopodia	as	well	as	of	EPS8	and	 IRSp53	 levels.	 This	 phenotype	was	 completely	 reversed	by	depletion	 of	 MITF	 or	 TFEB	 and	 TFE3,	 demonstrating	 that	 the	upregulation	 of	 these	 transcription	 factors	 could	 contribute	 to	the	invasive	phenotype	of	melanoma	cells.		Altogether	these	data	revealed	a	new	role	of	MITF	transcription	factors	 as	 regulators	 of	 a	 transcriptional	 program	 that	 could	control	metastatic	cancer	initialization.			
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1.1 MiT/TFE	family	of	bHLH-LZ	transcription	factors	
	The	 transcription	 factor	 EB	 (TFEB)	 is	 a	 member	 of	microphthalmia	 family	 of	 basic	 helix-loop-helix	 leucine-zipper	(bHLH-Zip)	transcription	factors	(MiT	family).	MiT	 family	 is	 composed	 of	 4	 different	 factors:	microphthalmia-associated	 transcription	 factor	 (MITF),	 TFEB,	 TFE3	 and	 TFEC1	(Fig.	1).		All	the	factors	of	MiT	family	share	a	common	basic	region	needed	to	 DNA	 binding	 sequence	 and	 involved	 in	 their	 dimerization;	outside	 of	 this	 identical	 region,	 they	 differ	 in	 all	 the	 others	regions1,	 and	 while	 TFEB,	 TFE3	 and	 MITF	 are	 more	 similar	among	 themselves	 sharing	 the	 same	 activation	 domain2,	3	 ;	 this	domain	lacks	in	TFEC,	that	it	appears	to	be	more	divergent	factor	and	seems	to	be	involved	in	a	negative	feedback	loop	mechanism	working	as	inhibitor	rather	than	activator	4.		All	 the	 members	 of	 the	 MiTs	 family	 are	 able	 to	 bind	 a	palindromic	 sequence	 CACGTG	 E-box;	 this	 motif	 is	 also	recognized	 by	 other	 bHLH-Zip	 transcription	 factors	 as	 MYC	 or	MAX	 or	 MAD5,	 although	MiT	 transcription	 factors	 are	 the	 only	one	 that	 can	 bind	 a	 non	 palindromic,	 asymmetric	 sequence	TCATGTG	 M-box6.	 Moreover,	 MiT	 transcription	 members	 are	able	 to	 form	 of	 both	 homodimers	 and	 heterodimers	 with	 any	members	 of	 the	 family	 5,7,	 but	 they	 are	 not	 able	 to	 form	
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heterodimers	 with	 other	 members	 of	 bHLH-Zip	 transcription	factors	family5.		
	
Fig.	 1	MiT	 family	of	 transcription	 factors.	 (Image	adapted	 from	Napolitano	et	al.,	2016)		Furthermore,	 the	 protein	 members	 of	 the	 MiT	 family	 are	 all	conserved	 in	 vertebrates;	 a	 single	 MiT	 component	 is	 ortholog	and	 is	 found	 in	 invertebrate	 organisms;	 indeed,	 in	 Drosophila	melanogaster	 the	 only	 component	 present	 is	 called	 Mitf	 8,	whereas,	 in	 Caenorhabditis	 elegans	 there	 is	 HLH-309.	 The	orthologs	 MiT	 present	 in	 invertebrates	 conserve	 the	 basic	regions	and	HLH-Zip	domains10,	suggesting	that	they	are	able	to	bind	DNA	in	a	way	that	is	similar	to	mammalian	MiT	members.	The	 presence	 of	 a	 single	 transcription	 factor	 in	 invertebrates	suggests	 that	 a	 common	 ancestral	 gene	 underwent	 multiple	rounds	 of	 duplication,	 and	 this	 allowed	 a	 functional	specialization	of	4	different	mammalian	MiT	proteins10.	
	
	
1.1.1	Transcription	factor	EB	(TFEB)	as	master	regulator	of	
lysosomal	function	
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Lysosomes	 are	 specialized	 organelles,	 containing	 an	 array	 of	enzymes	 that	 are	 important	 for	 degradation	 of	waste	materials	inside	of	the	cell.	Because	 of	 their	 prominent	 role	 in	 intracellular	 degradation,	lysosome	has	been	viewed	as	a	 “static”	organelle	 that	performs	“routine”	 work	 for	 the	 cell,	 mostly	 pertaining	 degradation	 and	recycling	 of	 cellular	 waste.	 In	 recent	 years,	 however,	 this	perception	 of	 lysosomes,	 as	 more	 degradative	 organelles,	 has	started	 to	 change	 with	 the	 realization	 that	 they	 participate	 in	many	other	cellular	processes	 like	secretion,	plasma	membrane	repair,	 signaling,	 energy	 metabolism,	 tumor	 invasion	 and	metastasis	 (Fig.	 2)11.	 Moreover,	 lysosome-based	 signaling	 and	degradation	 are	 subject	 to	 reciprocal	 regulation,	 indeed	transcriptional	 programs	 control	 the	 biogenesis,	 the	composition,	and	the	abundance	of	lysosomes	and	fine-tune	their	activity	to	match	the	metabolic	needs	of	the	cell12,13.		
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Fig.	2	Different	cellular	process	in	which	are	involved	lysosomes	(Image	adapted	from	Jing	et	al.,	2016)		A	recent	and	important	discovery	shows	that	TFEB,	a	member	of	MiT	 family,	 is	 the	master	 transcription	 factor	 that	 controls	 this	transcriptional	program14.	Bioinformatic	analysis	of	 lysosomal	promoter	genes	showed	the	presence	of	a	common	10-bases	E-box-like	palindromic	sequence	called	 Coordinated	 Lysosomal	 Expression	 And	 Regulation	“CLEAR”	motif.	 This	 sequence	 is	 recognized	 and	directly	 bound	by	TFEB,	promoting	 the	expression	of	 the	entire	 gene	network,	that	share	the	CLEAR	sequence15,	16.	Indeed,	 when	 TFEB	 is	 overexpressed,	 there	 is	 an	 increase	 in	lysosome	number	and	 in	 the	production	of	 lysosomal	 enzymes;	the	 increase	of	 lysosomes	number	 and	 lysosomal	 enzymes	 lead	to	clearance	of	the	storage	materials	by	promoting	the	ability	of	
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cells	 to	 degrade	 lysosomal	 substrates15,	 resulting	 in	 an	enhancement	of	catabolic	pathway.		Moreover,	it	has	been	demonstrated	that	TFEB	is	involved	in	the	regulation	 of	 many	 others	 pathways	 that	 involve	 lysosomal	functions	like	autophagy	and	lysosomal	exocytosis16	(Fig.	3).		Indeed,	 the	 CLEAR	 site	 is	 present	 in	 the	 promoter	 of	 several	“autophagy-related”	 genes	 by	 which	 TFEB	 activation	 can	promote	 the	biosynthesis	 of	 new	autophagosomes,	 but	 also	 the	fusion	between	lysosomes	and	autophagosomes17.	TFEB	is	also	able	to	induce	the	clearance	of	undigested	materials	by	 a	 process	 called	 lysosomal	 exocytosis18	 by	which	 lysosomes	can	 fuse	 with	 the	 plasma	 membrane	 and	 secrete	 the	 digested	material	outside	the	cell.		Definitely,	 TFEB	 can	 be	 considered	 the	master	 regulator	 of	 the	transcriptional	 programs	 that	 controls	 the	 logic	 of	 the	 cellular	metabolic	organization	by	regulating	 lysosomal	activity.	 Indeed,	alterations	of	 this	 interconnection	cause	 the	pathophysiology	of	an	 ever-expanding	 spectrum	 of	 conditions,	 including	 storage	disorders,	neurodegenerative	diseases,	and	cancer.		
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Fig.	3	TFEB	regulated	processes	(Image	adapted	from	Napolitano	et	al.,	2016)	TFEB	 positively	 regulates	 the	 transcription	 of	 several	 genes	 involved	 in	lysosomal	 biogenesis,	 lysosomal	 proliferation,	 lysosomal	 exocytosis	 and	 induce	the	 expression	 of	 the	 genes	 involved	 in	 autophagic	 pathways,	 in	 mitophagy	pathways	and	in	lipid	catabolisms.				
1.1.2	TFEB	regulation			Since	 TFEB	 is	 a	 master	 regulator	 of	 cellular	 catabolism,	 its	activity	 is	 highly	 regulated	 by	 post	 transduction	 modification,	protein	interaction	and	localization	inside	the	cell19	(Fig.	4).	TFEB	localization	and	activity	depends	on	different	and	multiple	phosphorylation	states.	There	are	two	different	serines	that	play	
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a	crucial	role	in	TFEB	activation.		When	TFEB	is	phosphorylated	on	S14217,20	and	S21120,21,22	it	is	blocked	into	the	cytoplasm	in	its	inactive	status15,17.	When	TFEB	is	dephosphorylated,	it	is	able	to	translocate	 to	 the	nucleus	where	 it	 is	 able	 to	 activate	 its	 target	genes.	 Nutrient	 deprivation,	 starvation	 or	 lysosomal	 stress	 are	the	 conditions	 by	 which	 TFEB	 translocate	 to	 the	 nucleus.	Mutation	 Ser-to-Ala,	 for	 both	 S142	 and	 S211,	 results	 in	 a	TFEB	constitutively	and	active,	that	stays	into	the	nucleus21,22,17,20.	In	 rich	 nutrient	 conditions,	 two	 kinases,	 mechanistic	 target	 of	rapamycin	 complex	 1	 (mTORC1),	 and	 extracellular	 signal-regulated	 kinase	 2	 (ERK2)	 21,22,17,20	 regulate	 TFEB	phosphorylation.	In	this	condition,	mTORC	is	recruited	on	lysosomes	membrane23	by	 the	 small	 Ras-related	 GTP-binding	 (Rag);	 Rag	 is	 previously	activated	by	the	v-ATPase	complex	present	on	lysosomes,	that	in	turn	is	activated	by	GTPase	Rheb23-25.	Rag	 GTPase	 have	 a	 key	 role	 in	 TFEB	 phosphorylation	 because	they	are	able	to	bind	TFEB	and	block	it	on	the	lysosomal	surface,	promoting	its	phosphorylation	by	mTORC126.		In	 starvation	 condition,	 or	 in	 lysosomal	 stress	 condition,	mTORC1	 is	 released	 from	 the	 lysosome	 membrane	 and	 its	inactive23,	 at	 this	 point,	 TFEB	 is	 dephosphorylated	 by	 the	phosphatase	calcineurin;	 in	 turn,	 calcineurin	 is	activated	by	 the	increase	 of	 Ca2+,	 released	 from	 the	 lysosome	 through	 the	 Ca2+	channel	mucolipin1	(MCOLN1)27;	all	these	events	promote	TFEB	nuclear	translocation	and	its	activation	and	upregulation;	indeed,	
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in	 this	 condition	TFEB	 is	 in	active	 status	and	 is	 able	 to	activate	itself	in	a	positive	feedback	loop28.		
	
Fig.	4	TFEB	regulation	model	(Image	adapted	from	Napolitano	et	al.,	2016)	TFEB	 is	 induced	by	 starvation	 and	mediates	 the	 starvation	 response.	 In	 the	presence	 of	 nutrients,	 TFEB	 interacts	 with	 the	 LYNUS	 machinery	 and	 is	phosphorylated	by	mTORC1,	on	the	 lysosomal	surface.	This	phosphorylation	inactivates	TFEB	keeping	 it	 in	 the	 cytoplasm.	During	 starvation,	mTORC1	 is	no	longer	on	the	lysosome,	and	consequently,	TFEB	is	not	phosphorylated	and	it	translocates	into	the	nucleus,	where	it	induces	its	own	transcription	and	the	transcription	 of	 its	 target	 genes,	 like	 the	 genes	 involved	 in	 the	 lysosomal-autophagy	pathway.				The	same	regulation	of	TFEB	occurs	also	for	the	other	members	of	MiT	family.		In	nutrient	availability	TFE3	is	sequestered	on	lysosomes	by	the	binding	with	Rag	GTPase,	where	 it	 is	 phosphorylated	 by	 active	mTORC1,	resulting	inactive29.	Again,	 a	 similar	 activation	 mechanism	 is	 shared	 by	 MITF.	 It	 is	phosphorylated	by	mTORC1	and,	in	this	inactive	state	is	retained	on	the	lysosome	by	Rag	GTPase26.	
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1.2 TFEB	and	MiT	family	in	tumorigenesis		In	the	past	few	years,	mutations	involving	TFEB,	TFE3	and	MITF	genes	 had	 been	 identified	 in	 different	 cancerous	 condition.	Amplifications	 and	 activating	 mutations	 of	 the	 MITF	 gene	 had	been	 observed	 in	 melanoma,	 and	 in	 some	 forms	 of	 hereditary	Renal	Cell	 Carcinoma30,	31,	whereas	 chromosomal	 translocations	leading	 to	 the	overactivation	of	TFEB	and	TFE3	genes	had	been	identified	 in	 sporadic	 Renal	 Cell	 Carcinomas	 herein	 referred	 as	
TFE-fusion	RCC32.		It	 has	 been	 found	 that	 a	 switch	 of	 6p21	 to	 11q13	 results	 in	 a	fusion	 of	 TFEB	 coding	 region	with	 the	 regulator	 of	 non-coding	
MALAT1	gene33,34.	 This	 event	 of	 translocation	 leads	 to	 a	 strong	increase	of	TFEB	full-length	protein	expression	35.	Altered	TFEB	expression	 or	 activity	 is	 associated	 with	 pancreatic	 cancer	 cell	proliferation36.	TFE3	 translocation	 and	 fusion	 with	 different	 genes37,38,39,40	 are	also	associated	with	renal	cell	carcinoma	(RCC):	for	example,	the	fusion	 between	 TFE3-ASPL	 leads	 to	 in	 alveolar	 soft	 part	sarcoma39.	Mutations	in	a	single	nucleotide	of	MITF	gene41,	or	amplification	of	MITF,	 are	associated	with	an	 increase	of	20%	of	 solid	 tumor	formation42,	43	.		
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In	 general,	 constitutive	 activation	 of	 MiT	 family	 members	 is	associated	with	pancreatic	tumorigenesis	and	is	fundamental	for	the	growth	of	pancreatic	ductal	adenocarcinomas	(PDAs)44.	MiTF	members	can	start	the	tumorigenesis	process	in	a	different	way;	 they	 can	 directly	 upregulate	 cell	 cycle	mediators,	 such	 as	cyclin	 D2,	 D3	 and	 p2145,46;	 moreover,	 they	 can	 induce	 the	activation	 of	 anti-apoptotic	 genes,	 such	 as	 BCL2	 or	 BIRC7	genes47,48.		The	overexpression	of	MiT	members	induces	the	upregulation	of	endo-lysosomal	 pathway	 that,	 in	 turn,	 can	 upregulate	 different	tumorigenic	 signaling	 pathway,	 such	 as	 WNT	 pathway,	 that	 is	altered	 in	 many	 types	 of	 cancer,	 and	 is	 the	 main	 actor	 of	 the	initiation	and	progression	of	malignant	modification36,49,50.	Moreover,	 it	 has	 been	 demonstrated	 that	 kidney-specific	 TFEB	overexpression	in	kidney	mice,	resulted	in	Renal	Carcinoma	and	hepatic	 metastases.	 In	 these	 conditions,	 the	 samples	 revealed	transcriptional	induction	and	enhanced	WNT	b-catenin	pathway.	At	 the	 opposite	 hands,	 inhibitions	 of	WNT	 signaling	 result	 in	 a	significant	rescue	of	the	phenotype	in	vivo51.	Finally,	 it	 has	 been	 demonstrated	 that	 mTORC1	 lysosomal	recruitment	 and	 activity	 depend	 directly	 by	 MiT/TFE	transcription	 factors	 and	 that	 this	 feedback	 loop	 mechanism	plays	a	role	in	cell	hyperproliferation	and	cancer	growth52.			
1.3 Filopodia	molecular	architecture	and	cellular	role	
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	The	 ability	 of	 cells	 to	 migrate	 in	 vivo	 is	 necessary	 for	 many	physiological	processes	including	embryonic	development,	tissue	homeostasis	and	wound	healing.	Cell	migration	is	also	implicated	in	 distinct	 pathological	 conditions	 such	 as	 inflammation	 and	cancer	metastasis38.	Cell	migration	 is	one	of	 the	more	 studied	processes;	 it	depends	on	two	different	cellular	protrusions,	lamellipodia	and	filopodia.		Lamellipodia	 are	 very	 sheet-like	 thin	 protrusions,	 0.1-0.2	 µm	filled	with	a	branched	network	of	actin.	Actin	filament	protrusions	are	polar	structures.	They	could	have	different	 growth	 rates,	 myosin	 can	 bind	 actin	 filament	 in	 a	phenomenon	 known	 as	 barbed	 end;	 or	 in	 contrast,	 the	 slowly	growing	is	known	as	the	pointed	end.	For	both	 filopodia	 and	 lamellipodia,	 the	barbed	end	 is	 oriented	towards	the	plasma	membrane,	pushing	against	the	leading	edge	and	 promoting	 the	 formation	 of	 protrusions	 and	 cellular	migration	or	extension53,54.	In	 the	 filopodium,	 some	 actin-bundling	 protein,	 as	 Fascin,	 are	able	to	pack	tightly	the	actin	filament	in	parallel	bundles	against	the	plasma	membrane.	This	 unidirectional	 organization	 allows	 for	 molecular	 motors,	such	MYOX,	to	transport	several	proteins	along	the	filaments,	to	the	filopodium	tip.	All	these	processes	are	useful	to	maintain	the	stability	of	the	filopodia,	but	also	to	test	the	environment	and	cue	
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sensing,	 to	establish	the	cell-cell	 junctions	and	for	the	transport	of	molecules	to	long-distances.	Historically,	 filopodia	are	considered	as	cellular	 “antennae”	 that	are	 able	 to	 probe	 the	 environment;	 currently,	 it	 is	 known	 that	filopodia	 play	 several	 and	 fundamental	 roles	 in	 physiologic	processes.	Filopodia	 are	 involved	 in	 many	 different	 processes,	 including	wound	 healing,	 adhesion	 to	 extracellular	 matrix,	chemoattraction	and	embryonic	development55,56.		Cells	 can	 organize	 a	 transport	 of	 different	 molecules	 through	filopodia,	 including	 receptors,	 from	 the	 inside	 of	 the	 cell	 to	 the	tips.	This	phenomenon	is	crucial	in	many	physiological	processes	including	 early	 embryonic	 development57,	 tissue	 patterning58,59,	dendritic	spine	 formation	and	mounting	of	an	effective	 immune	response60.	One	 of	 the	 most	 studied	 functions	 of	 filopodia	 is	 the	 role	 that	they	 play	 in	 cell	 migration;	 filopodia,	 indeed,	 are	 directly	connected	to	cell	migration	thanks	to	their	key	functions	that	can	improve	 cell	 motility.	 For	 this	 reasons,	 the	 abundance	 of	filopodia	 at	 the	 edge	 leading	 to	 the	 cells	 is	 considered	 a	characteristic	of	invasiveness	in	cancer	cell61.	Filopodia	 are	 able	 to	 transport,	 adhesion	 receptors,	 as	 well	 as	cytokines	from	the	base	adhesion	to	the	tips	of	filopodia	allowing	the	 cells	 to	 efficiently	 sense	 the	 environment.	 This	 type	 of	transport	 is	 important	 to	 strengthen	 cell-cell	 junctions62,63	 and	could	be	also	involved	in	collective	cell	migration64.	
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One	 more	 role	 of	 filopodia	 in	 cell	 migration	 is	 linked	 to	 ECM	tethering	 and	 probing	 through	 the	 transport	 of	 cell-ECM	adhesion	 receptors	 to	 filopodia	 tips.	 Indeed,	 transporting	integrins,	a	family	of	adhesion	receptors,	filopodia	play	a	central	role	 also	 in	 modulating	 cell	 adhesion;	 it	 is	 therefore	 not	 a	surprise	 that	 many	 cells	 use	 filopodia	 in	 early	 phases	 of	spreading65-67.			
1.3.1 	Filopodia	formation			Small	GTPases	of	Rho	superfamily	 is	 the	main	actor	 involved	 in	the	regulation	of	cell	morphology	and,	 in	particular,	 in	the	actin	cytoskeleton.		The	 best	 known	 GTPases	 are	 Rac1,	 CDC42	 and	 RhoA68;	 these	three	 proteins	 have	 different	 roles	 in	 the	 regulation	 of	 actin	cytoskeleton;	 Rac1	 promotes	 lamellipodia	 formation,	 CDC42	 is	involved	in	filopodia	formation	and	RhoA	is	implicated	in	stress	fiber	and	focal	adhesions69.	There	are	different	pathways	that	connect	the	action	of	CDC42	to	the	filopodia	formation.	The	most	studied	involves	the	activation	of	the	complex	ARP2/3,	through	activation	of	the	two	Nuclear	Promoting	Factors:	WASP	and	N-WASP70,71.	The	interaction	of	CDC42	with	WASP	and	N-WASP,	together	with	phosphatidylinositol-4,5-bisphosphate	(PtdIns(4,5)P2),	allow	the	
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change	 of	 the	 auto	 inhibited	 conformation	 of	 WASP	 and	subsequently	activation	of	ARP2/3	complex72.	A	 second	 and	 alternative	 mechanism	 of	 filopodia	 formation	involves	the	insulin-receptor	substrate	p53	(IRSp53),	which	is	an	I-BAR-domain/IM-domain-containing	 protein.	 This	 is	 a	 quite	large	 scaffold	 protein	 that	 is	 able	 to	 bind	 the	 small	 GTPase	CDC42,	 its	 effector	 WAVE2	 and	 the	 ENA/VASP	 family	 protein	MENA,	 and	 in	 this	 big	 complex	 acts	 to	 increase	 the	 rate	 of	 the	process	of	 filopodia	formation73.	 In	 literature,	 it	 is	reported	that	IRSp53	 bind	 MENA	 under	 the	 control	 of	 CDC42	 to	 induce	filopodia	 formation	 (Fig.	 5A);	 but	 IRSp53	 can	 also	 activate	WAVE2,	 downstream	 Rac1,	 activates	 the	 actin	 filament	nucleation	 of	 ARP2/3,	 and	 this	 complex,	 altogether,	 is	 able	 to	induce	lamellipodia	formation74,75	(Fig.	5B).	IRSp53	 can	 specifically	 bind	 another	 protein,	 that	 is	 called	EPS876.	 IRSp53	 and	 EPS8,	 are	 both	 weak	 bundlers;	 when	 they	interact	 forming	 IRSp53:	EPS8	complex	 their	bundling	action	 is	synergistically	enhanced.	Together,	they	are	able	to	bind	the	side	of	 the	actin	 filament	and	 form	a	 “filopodia	 initiation	complex”77	(Fig.	5).	Moreover,	 IRSp53	 in	 addition	 to	 its	 role	 to	 recruit	 the	 actin	regulator	 proteins	 to	 the	 site	 in	 which	 filopodia	 start,	 to	assembler,	induces	membrane	deformation,	facilitating	filopodia	formation78,79.		
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Fig.	 5	 Irsp53-based	 signaling	 circuitry	 regulating	 filopodia	 and	lamellipodia	extension	(Adapted	from	Scita	et	al.,	2008)		(a)	 Proposed	 model	 of	 the	 mechanism	 link	 Cdc42	 to	 the	 IRSp53-based	actin	regulatory	complex	leading	to	the	formation	of	filopodia;	IRSp53	can	be	associated	with	activated	Cdc42,	and	physically	connecting	this	GTPase	to	Eps8	(an	actin	capper	and	bundling	protein).	The	complex,	localized	to	the	 plasma	 membrane,	 contribute	 to	 the	 generation	 and	 proper	architectural	 organization	 of	 the	 linear	 actin	 bundles	 interconnected	giving	rise	to	filopodia		(b)	 Role	 of	 IRSp53	 in	 mediating,	 through	 WAVE-based	 machinery,	 the	extension	 of	 lamellipodia;	 The	 WAVE-based	 complex	 is	 key	 for	 the	generation	of	 the	Arp2/3-dependent	actin	meshwork.	 IRSp53,	 thought	 to	bind	with	WAVE	complex,	contributes	to	enhancing	and	confining	its	actin	polymerization	 activity	 along	 the	 tip	 of	 extending	 protrusion,	 thus	generating	the	forces	required	for	lamellipodia				
1.3.2 Molecular	composition	of	filopodia		A	large	number	of	proteins	are	important	to	generate	filopodia	in	different	tissues	and	organisms.	ENA/VASP	protein	 family	 is	a	 relatively	 large	group	of	proteins	that,	when	is	present	Profilin	protein,	have	anti-capping	activity;	
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it	means	 that	 they	 protect	 filaments	 from	 capping	 proteins80-82.	ENA/VASP	 protein	 typically	 localize	 at	 focal	 adhesions,	 at	 cell-cell	 contacts,	 at	 the	 leading	 edge	 and/or	 at	 the	 tips	 of	filopodia83,84.	Formins	 are	proteins	 that	 induce	 filopodia	 formation.	They	 can	form	 unbranched	 actin	 filaments	 by	 processed	 barber-end	nucleation	and	elongation.	Myosins	 form	 a	 large	 family	 of	motor	 proteins	 that	 are	 able	 to	walk	on	actin	 filament	 to	 the	 filopodia	 tips.	The	unconventional	MYOX	induces	filopodia	formation,	extension	and	stabilization	85.		Finally,	 Fascin,	 is	 an	 actin	 filament-bundling	 proteins,	 essential	for	the	maintains	of	tight	F-actin	bundles	of	filopodia86	(TAB.	1).		
	
TAB.	1	Adapted	from	Mattila	et	al.,	2008	
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	Historically,	 there	 were	 two	 different	 models	 of	 filopodia	formation.	The	 first	 one	 is	 named	 “convergent	 elongation	 model”;	 this	model	predicts	the	filopodia	formation	from	the	lamellipodial	F-actin	network	and	a	continue	actin	bundle	extension	of	filopodia.	According	to	this	model,	a	subset	of	ARP2/3	complex-nucleated	actin	filaments	is	protected	from	capping	and	clustered	with	tip-complex	proteins	such	as	ENA/VASP,	MYOX	end	Dia255.	The	second	model	considers	a	“de	novo”	 formation	of	 filopodia;	According	to	this	model,	 they	are	nucleated	at	 filopodial	 tips	by	formins.	To	 date,	 the	 working	 models	 show	 filopodia	 initiation	 by	 the	convergence	 of	 uncapping	 and	 formin-nucleated	 actin	 filament.	The	 elongation	 of	 the	 initial	 protrusion	 involves	 the	 use	 of	mechanical	forces	to	deform	the	plasma	membrane.	This	process	is	 enhanced	 by	 I-BAR	 domain	 protein,	 such	 as	 IRSp53.	 The	subsequent	 elongation	 is	 allowed	 thanks	 to	 the	 crosslink	 with	ENA/VASP	 and	 fascin;	 MYOX,	 in	 this	 model,	 is	 important	 to	stabilize	 elongation	 phase,	 in	 addition	 to	 its	 role	 in	 the	transportation	of	filopodial	component	to	the	tips87	(Fig.	6).		
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Fig.	6	A	working	model	 for	 filopodia	 formation	(Adapted	from	Mattila	et	al.,2008)	The	model	describes	the	role	of	the	different	key	proteins	during	filopodia	formation.		a. A	 subset	 of	 existing	 uncapped	 actin	 filaments	 are	 targeted	 at	 the	plasma	 membrane	 to	 be	 elongated	 by	 the	 Dia2	 and	 by	 ENA/	 VASP	proteins.	 Moreover,	 Dia2	 also	 nucleates	 the	 formation	 of	 new,	unbranched	actin	filaments.	The	barbed	ends	of	these	elongating	actin	filaments	 are	 converged	 together	 through	 myosin-X,	 leading	 to	 the	initiation	of	a	filopodium.		b. When	 the	 preliminary	 filopodium	 begins	 to	 push	 the	 plasma	membrane,	IRSp53	facilitates	plasma	membrane	protrusion	deforming	the	plasma	membrane.		c. The	 incorporation	of	 fascin	 in	 the	 shaft	of	 the	 filopodium	generates	a	stiff	actin	filament	bundle.	At	this	stage,	myosin-X	localize	in	filopodium	tip			
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1.3.3 Membrane	protrusions	at	the	leading	edge		In	order	to	move,	the	cell	extends	different	types	of	protrusions	from	the	plasma	membrane,	forward	the	leading	edge88.	The	cells	are	able	to	extend	lamellipodia,	blebs	and	invadopodia	to	coordinate	cell	migration.	Lamellipodia	 come	 out	 from	 the	 thin	 sheet-like	 at	 the	 leading	edge89.	 The	 dynamic	 lamellipodia	 protrude	 outside	 from	 the	cells88,	from	a	more	stable	region,	called	lamella90.		Invadopodia	were	first	described	as	actin-rich	matrix-degrading	protrusion91	 because	 they	 are	 able	 to	 degrade	 the	 extracellular	matrix	 during	 the	 invasion92,93.	 Invading	 cells	 extend	 their	 long	protrusios	three	dimensions93-95,	to	this	end,	the	invadopodia	use	the	force	of	actin	polymerization.		The	 very	 difference	 between	 filopodia,	 lamellipodia	 and	invadopodia	is	the	degrade	action,	that	is	specific	to	invadopodia;		Indeed,	 invadopodia	 contain	 vesicles	 with	 matrix-degrading	proteases,	 in	 particular,	 membrane	 type	 1	 metalloprotease	(MT1-MMP).		Finally,	 cells	 can	migrate	 also	 thanks	 to	 blebs.	 They	 have	 been	observed	in	multiple	cancer	cell96,97.		The	 blebs	 formation	 depend	 on	 strong	 pressure	 against	 the	plasma	membrane98.	In	migrating	cells,	blebs	are	not	retractable	but	new	blebs	are	generated	from	existing	one99.		Filopodia,	 lamellipodia	 and	 blebs	 can	 coexist	 at	 the	 cellular	leading	edge;	they	are	not	exclusive100;	although	the	presence	of	
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filopodia	and	 lamellipodia	 leads	 to	a	decrease	of	blebs	and	vice	versa101	 because	 the	 mechanical	 processes	 of	 formation	 are	opposite.	 Blebs	 require	 a	 decrease	 of	 actin	 filament	 interaction	with	 the	plasma	membrane,	on	 the	other	 side,	 the	 formation	of	filopodia	 and	 lamellipodia	 require	 an	 increase	 of	 actin	interaction	with	the	plasma	membrane.			
1.3.4 Filopodia	function	in	cancer	cell	invasion			Known	the	role	of	filopodia	in	cell	migration,	it	is	not	surprising	that	 filopodia	have	been	 associated	 and	observed	 in	 the	 cancer	cell	and	that	they	could	have	a	role	in	migration	and	invasiveness	in	the	tumor	microenvironment102.	Moreover,	filopodia	appear	to	be	 critical	 also	 in	 driving	 cancer	 cell	 metastasis	 and	 in	 the	dissemination	of	carcinoma	cell	at	secondary	organs103.	Clinical	 data	 suggest	 that	 filopodia	 have	 a	 fundamental	 role	 in	cancer	 cell	 dissemination	 and	 many	 filopodial	 proteins	 are	upregulated	in	human	cancer	cells.	The	 best	 example	 is	 Fascin;	 Fascin	 in	 completely	 absent	 in	healthy	 epitelium104	 but	 is	 overexpressed	 in	 many	 metastatic	cancers.	 Overexpression	 leads	 to	 an	 increase	 in	 motility	 and	invasion61,105	 whereas,	 when	 Fascin	 is	 deleted	 the	 cell	invasiveness	is	reduced106.	Also,	the	regulation	of	MYOX	is	involved	in	different	stages	from	healthy	to	cancer	cell.	Indeed,	the	expression	of	MYOX	increases	
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in	 breast	 cancer65,107,	 and	 the	 overexpression	 increases	 the	number	of	filopodia	per	cells108.	On	the	contrary,	the	silencing	of	MYOX	 inhibits	 the	 cellular	 invasion65,107.	Moreover,	 it	 is	 known	that	MYOX	is	increased	in	the	condition	of	p53	gain-of-function,	a	common	feature	of	metastatic	human	cancer65.	Other	 filopodia	 proteins	 are	 also	 implicated	 in	 cancer	 cell	invasion,	 such	 as	 IRSp53	 and	 EPS8,	 that	 are	 fundamental	 to	initiate	filopodia	formation67,109,	the	formin	mDia2110,111,	and	the	cytoskeleton	regulator	ENA/VASP112.	
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Chapter2	
Aims	of	the	Thesis	
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Historically,	 the	 transcription	 factor	 TFEB	 has	 been	 always	considerate	the	master	regulator	of	lysosome	functions.		Indeed,	 as	 previously	 described	 in	 this	 thesis,	 it	 has	 been	demonstrated	 that	TFEB	overexpression	promotes	 all	 the	 steps	of	the	lysosomes-autophagosomes	axis,	increasing	the	number	of	lysosomes	 and	 autophagosomes,	 the	 frequency	 of	 their	 fusion	and	 the	 rate	of	 substrate	degradation17.	These	 results	 indicated	that	TFEB	is	the	true	master	regulator	of	cellular	catabolism	and	coordinate	 the	 ability	 of	 the	 cell	 to	 respond	 and	 to	 adapt	 to	external	cues.	The	 goal	 of	 this	 project	 is	 to	 demonstrate	 a	 new	 and	 unknown	role	of	TFEB	as	the	master	regulator	of	genes	that	are	involved	in	actin	 remodelling.	 By	 preliminary	 experiments,	 I	 could	 observe	that	TFEB	overexpression	 causes	 changes	 in	 cellular	 shape	 and	increases	 in	 their	ability	 to	migrate.	Starting	of	 this	preliminary	data,	 the	 aim	of	my	Ph.D.	 project	 has	 been	 the	 identification	 of	the	genes	involved	in	the	actin	cytoskeleton	remodeling	and	the	formal	demonstration	of	their	direct	regulation	by	TFEB.			In	 particular,	 I	 found	 that	 TFEB	 can	 regulate	 genes	 involved	 in	the	formation	of	filopodia	and	I	revealed	a	molecular	mechanism	through	 which	 filopodia	 induction	 can	 mediate	 cancer	 cell	invasiveness.		The	specific	aims	of	my	Ph.D.	project	have	been:		
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i) Validation	 of	 filopodia	 gene	 network	 in	 TFE	
transcription	factors	dependent	way.		
	Starting	from	the	observation	that	TFEB	overexpression	induces	cell	 shape	 change	 and	 increase	 their	 ability	 to	 migrate,	 first,	 I	generated	 a	 list	 of	 "actin-related"	 genes	 that	 could	 be	 the	putative	target	of	TFEB.		To	 validate	 these	 genes,	 I	 performed	 qRT	 PCR	 analysis	 in	different	 experimental	 conditions	 and	 I	 identified	 EPS8	 and	IRSp53,	 two	 genes	 that	 play	 an	 important	 role	 in	 filopodia	formation,	 as	 genes	 that	 are	 regulated	 by	 TFEB	 and	 TFE3.	 By	using	HeLa	cells	I	found	an	increased	level	of	RNA	and	protein	of	IRSp53	 and	 EPS8	 in	 TFE	 transcription	 factors	 overexpression	and	 overactivation	 conditions,	 and,	 as	 expected,	 a	 decreased	level	 of	 RNA	 and	 protein	 of	 these	 genes	 in	 TFE	 transcription	factors	KD	conditions.	In	 agreement	 with	 these	 results,	 the	 number	 of	 filopodia	 was	increased	 and	 decreased	 in	 the	 same	 experimental	 conditions,	respectively.		By	 ChiP	 experiments,	 I	 also	 demonstrated	 that	 the	 EPS8	 is	 a	direct	target	of	TFEB.		
ii) Validation	of	the	filopodia	network	in	a	Melanoma	cell	
line		
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Using	a	model	of	the	cancer	cell,	the	melanoma	cell	line,	501-Mel,	that	 shows	 high	 expression	 level	 of	 the	 MITF,	 I	 found	 an	increased	 level	 of	 IRSp53	 and	 EPS8	 protein,	 and	 an	 increased	number	 of	 the	 filopodia;	 phenotypes	 that	 were	 rescued	 by	Knock-down	of	the	MITF,	TFEB,	and	TFE3	transcription	factors.		
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Chapter3	
Materials	and	Methods		
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3.1	Cell	culture,	treatments,	transfections	and	plasmids	
	HeLa	cell	lines	were	purchased	from	ATCC	and	cultured	in	MEM	(Invitrogen);	 The	 501Mel	 cells	 were	 a	 kind	 gift	 from	 Ruth	Halaban	 (26),	 and	 the	 A375P	 were	 from	 Colin	 Goding	 (27).		501Mel	cells	were	cultured	in	RPMI	(Invitrogen);	All	the	cell	lines	were	 supplemented	with	 10%	FBS,	 1%	penicillin/streptomycin	and	2mM	L-Glutamine	(Euroclone).	Cells	were	grown	at	5%	CO2	at	37°	C.		Starvation	treatments	were	performed	in	HBSS-10mM	Hepes	or	in	 RPMI	 media	 without	 amino	 acids	 supplemented	 with	 10%	FBS.	Cells	were	rinsed	twice	with	starvation	medium,	 then	kept	in	a	full	volume	of	starvation	medium	for	6h.	Human	 full-length	 TFEB-GFP,	 human	 full-length	 TFEB	S142/211A,	 and	human	 full-length	TFE3-GFP	were	used	 in	 this	study.	Cells	 were	 transfected	 with	 TransIT-LT1	 Reagent	 (Mirus)	following	the	manufacturer’s	protocol.		All	data	are	collected	48h	post-transfection	for	RNA	and	protein	analysis.		siRNAs	 were	 bought	 at	 Dharmacon.	 siRNA	 transfection	 was	performed	 with	 Lipofectamine	 RNAi	 max	 (Invitrogen)	 using	 a	reverse	 transfection	protocols	and	plated	 in	6-well	dishes.	Cells	transfected	with	 siRNAs	 (20nM)	were	 collected	 after	 72h	 since	transfection.		
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3.2	 RNA	isolation	and	reverse	transcription	
	To	 obtain	 purified,	 high-quality	 (DNA-free)	 total	 RNA,	 RNA	isolation	from	cell	lines	was	used		RNeasy	Mini	Kit	(QIAGEN).	Before	 use,	 the	 β-Mercaptoethanol	 was	 added	 to	 Buffer	 RLT	(RTL:	 β	 -Me	=	 100:	 1).	 	 The	 cell	 pellets	 from	 confluent	 100mm	plates	 were	 suspended	 in	 Buffer	 RLT	 (700	 μL).	 The	 volumes	were	 added	 in	 QIAshredder	 columns	 and	 centrifuged	 at	maximum	speed	for	3	minutes	to	fully	homogenize	the	cells.	The	lysate	is	homogenized	as	it	passes	through	the	spin	column.	Then	1	volume	of	70%	ethanol	was	 added	 to	 the	 eluate	of	 each	 tube	and	 mixed	 well	 by	 pipet.	 Ethanol	 is	 necessary	 to	 create	conditions	that	promote	selective	binding	of	RNA	to	the	RNeasy	membrane.	 Thereafter,	 each	 sample	 has	 been	 transferred	 in	RNeasy	mini	columns	and	the	columns	have	been	centrifuged	at	10000	rpm	for	30	seconds.	The	flow-through	has	been	discarded.	Then	 700	 μL	 of	 Buffer	 RW1	 was	 added	 to	 each	 column	 and	centrifuged	at	11000	rpm	 for	30	seconds.	Also,	 in	 this	case,	 the	flow-through	has	been	discarded.	After	44	mL	of	100%	Ethanol	was	added	to	Buffer	RPE	and	500	μL	 of	 the	 final	 buffer	was	 added	 to	 the	 columns,	 centrifuged	 at	11000	rpm	for	30	seconds.	The	flow-through	was	discarded.	This	step	has	been	repeated	twice.	The	RNeasy	columns	were	transferred	into	fresh	microcentrifuge	tubes.	 RNase	 free	 water	 (30	 μL)	 was	 added	 directly	 to	 the	
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columns	 and	 centrifuged	 at	 11000	 rpm	 for	 1	minute.	 This	 step	has	 been	 repeated	 by	 using	 the	 precedent	 eluate	 in	 order	 to	obtain	a	higher	final	RNA	concentration.	The	 final	 RNA	 concentration	 was	 determined	 by	spectrophotometric	analyses	(Nanodrop	technology),	measuring	the	 absorbance	 at	 260	 nm	 and	 the	 RNA	 purity	 was	 evaluated	according	to	the	A260/A280	and	A260/A230	ratio.	RNA	 was	 converted	 into	 a	 complementary	 molecule	 of	 DNA	(cDNA)	 through	 the	 reverse	 transcriptase	 enzyme	 and	nonspecific	 primers	 (random	primers)	 by	 using	 the	QuantiTect	Reverse	Transcription	Kit	(QIAGEN).	In	particular,	1	μg	RNA	was	reverse	transcribed	for	each	sample.	Purified	RNA	was	incubated	in	gDNA	Wipeout	Buffer	(2	μL)	for	5	minutes	 at	 42°C,	 to	 effectively	 remove	 contaminating	 genomic	DNA.	Thereafter,	6	μL	of	master	mix	were	added	for	each	sample:	-	4	μL	Quantiscript	RT	Buffer	-	1	μL	Quantiscript	Reverse	Transcriptase	-	1	μL	RT	Primer	Mix	They	were	incubated	for	30	minutes	at	42°C	and	for	3	minutes	at	95°C.	Finally,	 they	are	diluted	to	obtain	33	ng/μL	and	stored	at	 -20°C	until	used	for	qRT-PCR.	
	
	
3.3	Real-Time	PCR	
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	qReal-Time	PCR	 is	a	major	development	of	PCR	technology	that	enables	 reliable	 detection	 and	 measurement	 of	 products	generated	during	each	cycle	of	PCR	process.	The	 process	 uses	 reverse	 transcription	 polymerase	 chain	reaction	 (RT-PCR),	 coupled	 with	 fluorescent	 chemistry,	 to	measure	 variations	 in	 transcriptome	 levels	 between	 samples.	The	amount	of	product	is	directly	related	to	the	fluorescence	of	a	reporter	dye.	qReal	Time-PCR	was	performed	by	using	Power	SYBR	Green	PCR	Master	Mix	(Roche).	SYBR	Green	 I	 is	 an	 asymmetrical	 cyanine	dye	used	as	 a	nucleic	acid	 stain	 in	molecular	 biology.	 SYBR	Green	 I	 bind	 to	DNA.	The	resulting	 DNA-dye-complex	 absorbs	 blue	 light	 (λmax	=	 497	 nm)	and	emits	green	light	(λmax	=	520	nm).	Thus,	an	increase	in	DNA	product	 during	 PCR,	 therefore,	 leads	 to	 an	 increase	 in	fluorescence	intensity	measured	at	each	cycle.	Every	single	reaction	has	a	final	volume	of	20	μL	which	consists	of:		•	7,5	μL	of	SYBR	Green	•	 	 1	 μL	 of	 10	 μM	 forward	 primer	 and	 1	 μL	 of	 10	 μM	 reverse	primer	•	2,5	μL	of	H2O	•	3	μL	of	cDNA	previously	diluted	with	130	ul	of	water		
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The	mix	for	each	gene	analyzed	and	for	GAPDH	(Glyceraldehyde-3-phosphate	dehydrogenase),	which	has	been	used	to	normalize	mRNA	levels,	was	prepared.	Each	 sample	 was	 analysed	 in	 duplicate	 and	 for	 each	 gene	 was	used	 a	 negative	 control	 (mix	where	 cDNA	was	 replaced	 by	 the	water).	The	experiment	has	been	plated	 in	a	96-well	Real-Time	PCR	plate	 (LightCycler®	480	multiwell	 plate)	 and	 closed	with	 a	sealing	foil	giving	protection	against	evaporation.	The	Real-Time	plate	was	analysed	by	LightCycler®	96	Instrument	(Roche).		The	2-ΔΔCt	formula	was	used	to	calculate	the	relative	expression	of	the	target	gene.	The	Ct	 (threshold	cycle)	value	 is	 the	cycle	number	at	which	 the	fluorescence	 generated	 within	 a	 reaction	 crosses	 the	fluorescence	 threshold,	 a	 fluorescent	 signal	 significantly	 above	the	background	fluorescence.	At	the	threshold	cycle,	a	detectable	amount	of	amplicon	product	has	been	generated	during	the	early	exponential	 phase	 of	 the	 reaction.	 The	 threshold	 cycle	 is	inversely	proportional	to	the	original	relative	expression	level	of	the	gene	of	interest.		In	details,	it	has	been	calculated:	•	Average	of	each	sample	and	its	duplicate	(MEDIA	Ct);	•	ΔCt:	MEDIA	Ct	sample	-	MEDIA	Ct	of	loading	control;	•	ΔΔCt:	ΔCt	treated	samples	-	ΔCt	untreated	sample;	•	Relative	quantization:	RQ=	2-ΔΔCt	for	each	ΔCt	obtained.	
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The	primers	used	in	this	study	were	reported	in	the	table	below.		
PRIMERS	 Forword	 Reverse	
CDC42	 5'-TCTTCTCGGTTCTGGAGGCTC	 5'-ACTGTCAAGTATATGTGGAGTGT	
RIF	 5'-GGAAGGAGCTGAAGATCGTG	 5'-GTACTTCTCGAACACCGATGG	
ARPc2	 5'-GTGGTCATTGGAAAGGTGTTC	 5'-GGTTCCCTGTGGCTAAAGAG	
ARPc3	 5'-GTGGTAGATTGAAGCCAAAACC	 5'-GGCATACTTGGTAGAACTCAGG	
WASP	 5'-CCTACTTCATCCGCCTTTACG	 5'-GTCATCTCCAGCGAAGGTG	
WAVE	 5'-AAATACCTTTGCCTCTCGGG	 5'-GGTGTTGATTCCTTGCAGTG	
mDIA2	 5'-TTTCGTTATGTGCTCAATTGCCTT	 5'-GTAAGGAAATGACTGGTGACCCC	
FASCIN1	 5'-AAAGTGTGCCTTCCGTACC	 5'-CCACTCGATGTCAAAGTAGCAG	
IRSp53	 5'-GAGTTCTTTGGAGCCCTGG	 5'-AGAATTACGAGAAGGCACTGG	
EPS8	 5'-CAGGTGGATGTTAGAAGTCGAG	 5'-TTCCTGCTCATGATACTGCC	
TFEB	 5’-CCAGAAGCGAGAGCTCACAGAT	 5’-TGTGATTGTCTTTCTTCTGCCG	
TFE3	 5'-GATGAGATCATCAGCCTGGA	 5'-CAAGCAGATTCCCTGACACA	
MITF	 5'-GCTGGACAGGAGTTGCTGAT	 5'-GGGCTTGATGGATCCTGCTT	
RAGD	 5'-AGGTGACAAAGTTCCTGGCT	 5'-GCCGATTCTGAACCTTTCGA	
MUCOLIPIN1	 5’-TGGGACCCCAGCTTATTTATTT	 5’-CTGTGTCCGATTCGATCAGC	
NEU1	 5’-	CAGCACATCGAGTTCCGAG	 5’-TGTCTCTTTCCGCCATGAGGT	
HPRT	 5'-GCCGATTCTGAACCTTTCGA	 5'-GGTCCTTTTCACCAGCAAGCT			
3.4	Protein	extraction	
	To	prepare	samples	for	running	on	the	polyacrylamide	gel,	cells	need	to	be	lysed	to	release	proteins	of	interest.	Cell	 media	 was	 removed	 from	 the	 plates	 and	 the	 cells	 were	washed	 twice	 with	 1X	 PBS.	 PBS	 was	 removed	 as	 much	 as	possible	because	excess	liquid	can	decrease	the	concentration	of	lysates.	RIPA	lysis	buffer	(50	mM	Tris-HCl	pH	7.5,	1%	Triton	X-100,	150	mM	NaCl,	1	mM	EDTA,	0.1%	Na	deoxicholate)	was	prepared	by	
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adding	 protease	 inhibitor	 cocktail	 (1:100)	 and	 phosphatase	inhibitors	(1:1000).	It	 was	 added	 to	 the	 cell	 plates	 inappropriate	 amount	 and	incubated	 for	 10	minutes	 in	 order	 to	 be	 sure	 that	 RIPA	 is	well	distributed.	 Cells	 were	 scraped	 vigorously	 from	 the	 plate	 by	using	a	plastic	cell	scraper	that	helps	with	the	lysis	process.	Each	cell	 lysate	 has	 been	 transferred	 in	 eppendorf	 and	 sonicated	 at	appropriate	 intervals.	 	 Finally,	 the	 lysates	 were	 stored	at	-80°C	until	use.			
3.5	 BCA	analysis	
	Protein	extracts	have	been	quantified	by	using	 the	BCA	protein	assay.	The	 Pierce	 BCA	 Protein	 Assay	 is	 a	 detergent-compatible	formulation	 based	 on	 bicinchoninic	 acid	 (BCA)	 for	 the	colourimetric	 detection	 and	 quantitation	 of	 total	 protein.	 This	assay	primarily	relies	on	two	reactions.	First,	 the	 peptide	 bonds	 in	 proteins	 reduce	 Cu2+	 ions	 to	 Cu+	(a	temperature	dependent	reaction).	The	amount	of	Cu2+	reduced	is	proportional	 to	 the	 amount	 of	 proteins	 present	 in	 the	 solution.	Next,	 two	molecules	of	bicinchoninic	acid	chelate	with	each	Cu+	ion,	 forming	 a	 purple-coloured	 product	 that	 strongly	 absorbs	light	at	a	wavelength	of	562	nm.	
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The	working	 solution	has	been	prepared	by	mixing	50	parts	 of	BCA	 Reagent	 A	 (containing	 sodium	 carbonate,	 sodium	bicarbonate,	 bicinchoninic	 acid	 and	 sodium	 tartrate	 in	 0.1	 M	sodium	hydroxide)	with	1	part	of	BCA	Reagent	B	(containing	4%	cupric	sulphate).	Protein	concentrations	have	been	determined	and	reported	with	reference	to	standards	of	bovine	serum	albumin	(BSA).	A	series	of	dilutions	of	known	BSA	concentration	were	prepared	(0	μg/μl;	0,06	 μg/μl;	 0,125	 μg/μl;	 0,25	 μg/μl;	 0,5	 μg/μl;	 1	 μg/μl	 and	 2	μg/μl)	 and	 assayed	 alongside	 the	 unknowns	 samples.	 The	protein	 concentration	 of	 each	 unknown	 sample	 has	 been	determined	based	on	the	standard	curve.			
3.6	 Western	Blot	Analysis	
	After	the	quantification	of	the	proteins,	 it	has	been	prepared	30	μg	 of	 proteins	 for	 each	 sample.	 It	 has	 been	 added	 6X	 Laemmli	buffer	(4%	SDS,	20%	glycerol,	10%	2-mercaptoethanol,	0.004%	bromphenol	blue,		0.125	M	Tris	HCl)	to	samples.	The	 beta	 2-mercaptoethanol	 reduces	 intra	 and	 inter-molecular	disulfide	 bonds	 of	 the	 proteins.	 The	 SDS	 detergent	 binds	 to	 all	the	 proteins	 positive	 charges	which	 occur	 at	 a	 regular	 interval,	thus	giving	each	protein	the	same	overall	negative	charge	so	that	proteins	will	separate	based	on	size	and	not	by	charge.	The	SDS	also	denatures	the	proteins	to	also	help	separate	them	based	on	
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size,	 not	 on	 shape.	 Bromophenol	 blue	 serves	 as	 a	 migration	indicator	dye	where	 it	 is	 possible	 to	observe	 the	dye	 front	 that	runs	ahead	of	 the	proteins.	Bromophenol	blue	also	 functions	 to	make	 it	easier	 to	see	 the	sample	during	 loading	of	 the	gel	wells	with	protein	sample.	Glycerol	in	the	Laemmli	buffer	increases	the	density	of	the	sample	so	that	it	will	fall	to	the	bottom	of	the	well,	minimizing	puffing	or	loss	of	protein	sample	in	the	buffer.	The	protein	samples	were	boiled	for	5	minutes	at	95°	C	and	then	loaded	 in	 10%	 precast	 polyacrylamide	 gel	 to	 perform	 the	 SDS-PAGE	(SDS-polyacrylamide	gel	electrophoresis)	at	80V.	Before	 the	 end	 of	 running,	 PVDF	 membranes	 (Millipore	
Immobilon™	PVDF	Transfer	Membranes)	were	activated	with	prior	
to	 use.	 They	 were	 wet	 for	 30	 seconds	 in	 methanol.	 Then	 the	membranes	 were	 transferred	 to	 purified	 water	 for	 at	 least	 2	minutes.	 Finally,	 PVDF	 membranes	 were	 transferred	 in	 the	transfer	 buffer	 (100	mL	Blotting	Buffer,	 200	mL	Methanol,	 700	mL	H2O)	and	incubated	for	5	minutes.	
At the end of the running, the gel has been removed from its cast and 
gel and PVDF membranes were sandwiched between sponge and 
paper (sponge, paper, paper, gel, filter, paper, paper, sponge), 
making sure to get rid of air bubbles. It is important that the 
membrane is closest to the positive electrode and the gel closest to 
the negative electrode.  Electroblotting has been performed for 1 
hour at 4°C at 100 V. 
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This method is useful to further analyse proteins by using probes 
such as specific antibodies. Membranes were blocked in blocking 
buffer (5% skim milk in TTBS) for 1 hour at room temperature. Primary	antibodies	have	been	diluted	in	blocking	buffer	and	the	membranes	were	incubated	with	the	correct	primary	antibodies	overnight	at	4°C.	The	day	after	the	blots	has	been	rinsed	three	times	for	5	minutes	at	room	temperature.	The	 filters	 have	 been	 incubated	 in	 horseradish	 peroxidase	(HRP)-	 conjugated	 secondary	 antibody,	 diluted	 in	 blocking	buffer,	 for	1	hour	at	room	temperature.	After	1	hour	blots	have	been	rinsed	three	times	for	5	minutes	at	room	temperature.	ECL	(Enhanced	ChemiLuminescence)	has	been	used	to	detect	the	
antigen-antibody	 complexes	 on	 the	 blots.	 The	 ECL	 solution	contains	 a	 chemiluminescent	 substrate	 (luminol)	 and	 a	 strong	oxidizing	agent	(hydrogen	peroxide)	that	are	then	applied	to	the	blot.	Horseradish	 peroxidise,	 in	 presence	 of	 hydrogen	 peroxide,	catalyses	 the	 oxidation	 of	 luminol	 to	 3-aminophthalate.	 The	reaction	is	accompanied	by	the	emission	of	low-intensity	light	at	428	nm.	However,	in	the	presence	of	certain	chemicals,	the	light	emitted	 is	 enhanced	up	 to	1000-fold,	making	 the	 light	easier	 to	detect	 and	 increasing	 the	 sensitivity	 of	 the	 reaction.	 The	 signal	has	been	detected	by	Chemidoc	instrument.	The	primary	and	the	correlative	secondary	antibody	used	in	this	project	are	in	the	table	below.		
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AbI	 diluition	 AbII	 diluition	
EPS8	(BD)	 	1:1000		 Anti-Mouse/HRP	 	1:10000	
IRSp53	(SIGMA)	 	1:1000	 Anti-Rabbit/HRP	 	1:10000	
TFEB	(Cell	Signaling)	 	1:1000	 Anti-Rabbit/HRP	 	1:10000	
ACTIN	(SIGMA)	 	1:3000	 Anti-Mouse/HRP	 	1:10000			It	 has	 been	 used	 the	 software	 ImageJ	 to	 analyze	 western	 blot	images.	The	quantification	will	 reflect	 the	amounts	as	a	 ratio	of	each	 protein	 band	 relative	 to	 the	 loading	 control	 band	 of	 the	same	lane.			
3.7	 Immunofluorescence	Analysis	
	Immunofluorescence	(IF)	is	a	technique	that	uses	the	specificity	of	 antibodies	 to	 their	 antigen	 to	 target	 fluorescent	 dyes	 (also	called	 fluorophores	 or	 fluorochromes)	 to	 specific	 biomolecular	targets.	 Antibodies	 that	 are	 chemically	 conjugated	 to	fluorophores	 are	 commonly	 used.	 The	 fluorophore	 allows	visualization	 of	 the	 target	 distribution	 in	 the	 sample	 under	 a	fluorescent	 microscope	 (e.g.	 epifluorescence	 and	 confocal	microscopes).		IF	 utilizes	 a	 two-step	 technique.	 In	 the	 first	 step,	 a	 primary	unlabelled	 antibody	 binds	 to	 the	 target.	 In	 the	 second	 step,	 a	secondary	 antibody	 (directed	 against	 the	 Fc	 portion	 of	 the	
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primary	antibody),	conjugated	to	a	fluorophore,	is	used	to	detect	the	first	antibody.		Cells	 have	 been	 grown,	 counted	 and	 plated	 directly	 on	 the	coverslip.		The	cell	culture	medium	has	been	removed	from	the	plates	and	the	 cells	 have	 been	washed	 three	 times	 in	 PBS	 1X.	 	 Then,	 cells	have	been	fixed	with	4%	paraformaldehyde	(PFA)	for	10	minutes	at	 room	 temperature.	 Fixation	 is	 needed	 to	 immobilize	 the	antigens,	 while	 retaining	 authentic	 cellular	 and	 subcellular	architecture.	 	 In	particular,	 paraformaldehyde	 is	 a	 cross-linking	reagent	 that	 forms	 intermolecular	 bridges,	 thus	 creating	 a	network	of	linked	antigens.		Fixed	cells	were	washed	three	times	with	PBS	1X.		In	order	to	permeabilize	the	cells	and	block	unspecific	binding	of	the	 antibodies,	 fixed	 cells	 have	 been	 covered	with	 the	Blocking	Buffer	for	30	minutes	at	room	temperature.		Blocking	Buffer	has	been	prepared	in	PBS	1X	and	it	is	composed	by:	-	3%	BSA	(Bovine	Serum	Albumin)	-	0,05	%	Saponin		The	specific	primary	antibodies,	diluted	 in	blocking	buffer,	over	day	at	room	temperature	or	overnight	at	4°C,	depending	on	the	antibody.		
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The	cells	have	been	washed	three	times	with	blocking	buffer	for	5	minutes	each.	Subsequently,	 cells	 have	 been	 incubated	 with	 secondary	antibodies,	 diluted	 in	 blocking	 solution	 for	 1	 hour	 at	 room	temperature	 in	 dark	 conditions. In	 particular,	 the	 secondary	antibodies	 are	 raised	 against	 the	 host	 species	 used	 to	 generate	the	primary	antibody.		After	 1	 hour	 of	 incubation,	 cells	were	washed	 three	 times	with	blocking	solution	for	5	minutes	each.		Then,	 it	 has	 been	 added	 the	 DAPI	 (4',6-diamidino-2-phenylindole),	 diluted	 1:1000	 in	 blocking	 buffer,	 which	 is	 a	fluorescent	stain	that	binds	strongly	to	A-T	rich	regions	in	DNA.	When	 bound	 to	 double-stranded	 DNA,	 DAPI	 has	 an	 absorption	maximum	at	a	wavelength	of	358	nm	and	its	emission	maximum	is	at	461	nm.	It	is	useful	to	mark	the	nuclei.		After	 15	 minutes,	 cells	 were	 washed	 with	 PBS	 and	 coverslips	have	been	mounted	with	a	drop	of	mounting	medium	(ProLong®	Gold	Antifade	Mountant).	The	 coverslips	 have	 been	 sealed	 with	 nail	 polish	 to	 prevent	drying	and	movement	under	microscope	and	stored	at	4°C.	Finally,	 the	cells	were	 imaged	on	a	Carl	Zeiss	LSM	880	confocal	microscope	super	resolution	with	a	63x	oil	immersion	objective.		The	primary	and	the	correlative	secondary	antibody	used	in	this	project	are	in	the	table	below.		
AbI	 diluition	 AbII	 diluition	
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TFEB	(Cell	Signaling)	 	1:400	 Anti-Rabbit		 	1:800	
TFE3	(SIGMA)	 	1:400	 Anti-Rabbit	 	1:800	
MYOX	(SIGMA)	 	1:200	 Anti-Rabbit	 	1:800	
Phalloidin	(Invitrogen)	 	1:200	 		 	1:800			The	software	ImageJ	has	been	used	to	analyser	files,	to	merge	the	different	channels	and	to	count	the	filopodia	tips.			
3.8	 Cromatin	immunoprecipitation	analysis	(ChIP)	
	For	ChIP	experiments	were	used	a	pure	stable	clone	of	HeLa	cells	that	 overexpress	 TFEB-3xFLAG;	 they	 were	 starved	 with	 HBSS,	10µM	 Hepes	 for	 3	 hours	 and	 then	 counted	 and	 analysed.	 The	started	sample	contains	1x106	cell.		The	 ChIP	 is	 a	 technic	 that	 allows	 to	 identifying	 specific	 DNA	region	that	 is	bind	by	the	protein	of	 interest.	 	 It	 is	based	on	the	interaction	of	the	ammine	group	present	inside	the	proteins	and	the	DNA	basis,	through	the	formaldehyde.	Cells	were	 homogenised	 and	 fixed	 by	 formaldehyde	 1%	 for	 10	minutes	at	room	temperature	and	then	quenching	using	glycine	1x	added	at	the	resuspended	cells.	At	this	point	is	important	to	isolate	the	DNA	and	for	this	reason,	the	 cells	 are	 lysed;	 it	 is	 important	 to	 remove	 before	 the	cytoplasm	 and	 then	 proceed	 to	 the	 lysis	 of	 the	 nucleus.	 Cells	were	washed	 three	 times	 in	 cold	PBS	1X	 and	 then	 lysed	 in	 cell	
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lysis	buffer	(Pipes	5	mM	pH	8.0,	Igepal	0,5%,	KCl	85	mM)	for	15	min.	 Nuclei	 were	 lysed	 in	 nucleus	 lysis	 buffer	 (Tris	 HCl	 pH8.0	50mM,	EDTA	10	mM,	SDS	0.8	%)	for	30	min.		DNA	isolated	it	was	fragmented	using	Covaris	s220,	in	fragments	of	200-500	bp	by	sonication	with	alternated	cycles	of	30’’ON	and	30’’OFF	 for	 15	 times,	 and	 at	 this	 point,	 we	 obtain	 the	immunocomplex	that	interacts	with	the	protein	of	interest.		The	sheared	chromatin	was	immunoprecipitated	overnight	with	anti-Flag	 SIGMA	 (6ug	 per	 sample)	 to	 recognise	 TFEB-3xFLAG	present	 in	 overexpression	 in	 the	 stable	 clones	 used	 for	 ChIP	experiments.		The	immunoprecipitated	chromatin	was	incubated	3	hours	with	magnetic	 protein	 G	 beads	 (Dynabeads	 Protein	 G,	 Invitrogen).	Then,	beads	were	washed	with	wash	buffers	and	DNA	eluted	 in	elution	buffer	(Tris	HCl	pH8	50	mM,	EDTA	1	mM,	SDS	1%).		DNA	 was	 purified	 by	 ChIP	 DNA	 Clean	 and	 Concentrator	 kit	(ZYMO	RESEARCH)	and	it	was	analysed	by	RT-PCR.		The	primers	used	in	this	study	are	reported	in	the	table	below.		
PRIMERS	 Forword	 Reverse	
IRSp53	 5'-CTTTCGTCTCCGTCCTGCTG	 5'-GCATCTCCTCTGAGCGAGAC	
EPS8	 5'-CCCCATGCTGTCCTAACTTC	 5'-CACAAAGCAAGCAAGTCCAA	
MUCOLIPIN1	 5'-GCCCGCCGCTGTCACTG	 5'-AGGGGCTCTGGGCTACC	
RLP30	 5'-GGGGAACGAGAAAGGAAAGA	 5'-CCTTCTGCTTGCGATCTGTT		In	 this	 study,	 the	 enrichment	 of	 the	 specific	 site	 of	 obtained	 is	reported	 as	 %Input	 that	 means	 the	 quantity	 of	 DNA	
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immunoprecipitated	normalized	on	the	quantity	of	DNA	present	in	the	cells	before	the	immunoprecipitation.				
3.9	 Cell	Invasion	Assay	
	For	 Cell	 Invasion	 Assay	 experiments	 were	 used	 a	 pure	 stable	clone	of	HeLa	cells	that	overexpress	TFEB-3xFLAG	and	as	control	HeLa	wt	cells.		To	 start,	 the	 Invasion	 Chamber	 was	 adjusted	 at	 room	temperature	in	a	tissue	culture	hood	and	then	was	added	300μl	of	warm	serum-free	media	to	the	interior	of	the	inserts,	to	allow	rehydrating	the	ECM	layer	for	1-2	hours	at	room	temperature.	After	 that	 the	membrane	was	 rehydrated	 0.5x106	 cells/ml	was	plated	in	serum-free	media	and	complete	media,	containing	10%	fetal	bovine	serum,	was	added	to	the	lower	chamber.			The	experiment	was	left	in	the	incubator	for	30h.	Using	 a	 cotton-tipped	 swab	 gently	 was	 removed	 non-invading	cells	as	well	as	the	ECMatrix	gel	from	the	interior	of	the	inserts.	To	 be	 sure	 to	 remove	 cells	 on	 the	 inside	 perimeter,	 as	 any	remaining	 cells	 inside	 the	 insert,	 the	 procedure	 with	 a	 clean	cotton-tipped	swab	was	repeated	twice.			At	 this	 point,	 500μl	 of	 staining	 solution	 was	 added	 to	 the	unoccupied	wells	of	the	plate.		Stain	 invasive	 cells	 on	 the	 lower	 surface	 of	 the	 membrane	 by	dipping	 inserts	 remain	 in	 the	 staining	 solution	 for	 20	minutes.	
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Then	the	insert	was	washed	in	a	beaker	of	water	several	times	to	rinse,	and	then	the	insert	was	left	to	air	dry.			The	 images	 of	 the	 cells	 were	 taken	 by	 APOTOME	 ZEISS	microscope,	 and	 the	 colourized	 invasive	 cells	 were	 counted	 by	ImageJ	tool	“Count	Cell”.	
	
3.10	 Wound	Healing	Assay	For	Wound	Healing	assay	was	used	a	pure	stable	clone	of	HeLa	cells	that	overexpress	TFEB-3xFLAG	and	as	control	HeLa	wt	cells.	The	cells	were	seeded	in	multi-well	plates	and	culture	until	they	became	 confluent.	 Once	 they	 became	 confluent,	 using	 a	 yellow	pipette	tip	was	performed	a	straight	scratch,	simulating	a	wound.	At	 this	point,	 the	 images	were	acquired	at	 regular	 time	 interval	by	confocal	microscopy.		
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Chapter4	
Results																						
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4.1	 TFEB	 overexpression	 in	 different	 cell	 lines	 causes	 a	
drastical	change	in	cell	shape	
	The	idea	that	TFEB	could	have	a	role	in	actin	remodelling	starts	with	 the	 observation	 that	 in	 the	 condition	 of	 TFEB	overexpression,	different	cell	 lines	such	as	HeLa,	U2OS,	ARPE19	and	 COS7,	 show	 strong	 morphological	 changes	 in	 their	 shape		(Fig.	7).	In	order	to	detect	F-actin,	cells	were	stained	with	phalloidin	after	48h	 for	 transfection	with	 a	 construct	 coding	TFEB	 fused	 to	 the	GFP.	 	 In	 all	 the	 cell	 lines	 analyzed,	 I	 could	 observe	 the	 same	phenotype:	 in	 TFEB	 overexpression	 condition,	 the	 shape	 of	 the	cells	 was	 drastically	 changed	 when	 compared	 to	 the	 not	transfected	cells	 (control	 cells).	 In	particular,	 I	observed	 that	 in	cells	 overexpressing	 TFEB-GFP,	 there	 was	 an	 increase	 in	 the	numbers	of	 filopodia-like	 structure	outside	 the	 cells;	 structures	that	were	almost	absent	in	the	control	cells.			As	 shown	 in	 Fig.	 7,	 in	 COS7	 cells,	 that	 are	 commonly	 used	 to	conduct	 studies	 in	 filopodia	 formation113,	 after	 TFEB-GFP	transfection	I	could	observe	the	strongest	phenotype	in	terms	of	the	number	of	filopodia	when	compared	to	the	control	cells.	
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Fig.	7	Overexpression	of	TFEB	WT	in	HeLa,	U2OS,	ARPE19	and	COS7	cells	
induce	morphological	shape	changes	Fluorescence	 analysis	 of	 untransfected	 cells	 compared	 to	 transfected	 cells	with	 TFEB	wt	 isoform.	 HeLa	 cell	 line	 (upper),	 U2OS	 cell	 line	 (second	 line),	ARPE19	cell	line	(third	line),	COS7	(lower).	In	 blue	 DAPI:	 4',6'-diamidino-2-phenylindole	 staining;	 in	 green	 EGFP:	 fused	with	TFEB	wt	isoforms;	in	grey:	phalloidin	dye	against	actin	cytoskeleton.		Moreover,	 a	 wound	 healing	 assay	 using	 stable	 HeLa	 cell	 line	overexpressing	TFEB,	revealed	that	one	day	after	the	generation	of	 the	wound,	HeLa	wt	cells	were	not	able	 to	completely	 repair	
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the	wound	(Fig	8,	upper	panel);	overexpressing	TFEB	HeLa	cells,	start	to	repair	it	20	hours	after	the	wound	(Fig	8,	lower	panel).			
	
Fig.	8	TFEB	overexpression	increase	the	ability	of	cell	migration		Wound	Healing	assay	on	HeLa	wt	cells	and	HeLa	TFEB	overexpressing	stable	clone	 (CF7);	 The	 cells	 are	 analyzed	 or	 1day	 and	 the	 photograms	 are	extrapolated	by	the	movie.			From	these	preliminary	observations,	I	started	to	investigate	the	new	 role	 of	 TFEB	 in	 regulating	 genes	 involved	 in	 actin	remodeling	and	filopodia	formation.		
	
4.2	 Bioinformatics	 analysis	 reveals	 the	 presence	 of	 CLEAR	
binding	sites	in	the	promoters	of	actin	and	filopodia	related	
genes			To	understand	the	TFEB	involvement	in	actin	remodeling	and	in	filopodia	 initialization,	elongation	and	regulation,	 I	performed	a	bioinformatics	 analysis	 regarding	 the	 most	 important	 genes	involved	in	filopodia	network	(Tab.	2).	The	website	TFEB.tigem.it	previously	 developed	 at	 the	 Telethon	 Institute	 of	 Genetics	 and	
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Medicine	 (TIGEM),	was	 used	 to	 analyze	 the	 presence	 of	 CLEAR	binding	 sites	 on	 the	 promoter	 of	 genes	 involved	 in	 the	 actin	cytoskeleton	remodeling	and	the	filopodia	network.		In	this	database	are	stored	more	than	20000	genes	that	could	be	potentially	TFEB	target	genes.		From	 this	 interrogation,	 I	 generated	 a	 list	 of	 10	 genes	 (TAB.	 2)	that	could	be	potentially	regulated	by	TFEB	and	that	are	involved	in	the	actin	and	filopodia	related	processes.		
	
TAB.	2	Bioinformatic	analysis	of	filopodia	network	genes	In	 the	 table	 is	 reported	 the	 binding	 rank	 score,	 the	 presence	 or	 not	 of	 the	CLEAR	binding	sites,	and	the	positivity	at	ChIP	analysis13	of	the	principal	genes	involved	in	filopodia	network.			
4.3	 TFEB	 activation	 causes	 an	 increase	 in	 mRNA	 level	 of	
filopodia	genes	in	HeLa	cell		
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As	first	experiments	to	validate	this	list	of	actin-filopodia	related	genes,	I	performed	quantitative	RT-PCR	on	mRNA	extracted	from	HeLa	 cell	 overexpressing	 the	 TFEB	 wt	 isoform	 (wt-TFEB),	 the	TFEB	 S142/211A	 constitutively	 active	 isoform	 (S142/211A-TFEB)	and	TFE3	wt	 isoform	(wt-TFE3),	using	specific	oligos	 for	each	gene	(Fig.	9;	see	methods).	The	 qRT-PCR	 data	 revealed	 an	 increased	 mRNA	 level	 for	 two	genes:		EPS8	and	IRSp53.	These	genes	were,	indeed,	upregulated	in	the	condition	of	overexpression	of	wt-TFEB,	S142/211A-TFEB	and	wt-TFE3	when	compared	to	the	untransfected	cells	(Fig.	9).		EPS8	 and	 IRSp53	 are	 the	 most	 important	 genes	 involved	 in	filopodia	 elongation,	 therefore	 these	 results	were	 in	 agreement	with	 the	 previous	 observation	 of	 an	 increased	 numbers	 of	filopodia	in	cells	overexpressing	TFEB.			
	
	
	
	 59	
Fig.	9	RT-PCR	of	filopodia	network	genes	The	qRT-PCR	analysis	was	performed	on	the	principal	genes	involved	in	filopodia	formation	pathway	to	evaluate	 the	RNA	 levels	 in	wt-TFEB,	S142/211A-TFEB,	wt-TFE3	overexpression.	The	cells	were	collected	after	48h	post-transfection.		RAGD,	 Mucolipin1,	 NEU1	 are	 known	 TFEB	 gene	 target	 and	 are	 used	 as	 positive	control.		As	 mentioned	 before,	 TFEB	 has	 a	 very	 tight	 regulation.	 It	 is	activated	by	cellular	stress	or	by	starvation	conditions;	 in	 these	conditions,	it	migrates	into	the	nucleus	and	is	able	to	activate	the	transcription	 of	 its	 gene	 target.	 For	 this	 reason,	 I	 decided	 to	analyze	the	regulation	of	endogenous	TFEB	levels,	on	IRSp53	and	EPS8	in	different	starvation	conditions.	To	 this	 end	 I	 performed	qRT	PCR	 experiments	 in	 two	different	starvation	conditions;	1)	 total	 starvation,	 treating	 the	cells	with	HBSS	enriched	with	HEPES	10μM,	and	2)	amino	acids	starvation,	treating	 the	 cells	with	RPMI	media	without	 amino	 acids	 and	 in	absence	of	glutamine.		By	the	qRT	analysis,	I	could	observe,	that	like	 for	 the	 canonical	 target	 genes	 of	 TFEB	 (RAGD,	 NEU	 and	MCLN1),	I	was	able	to	appreciate	an	increase	of	IRSp53	(4	times)	and	 EPS8	 (5	 times)	 mRNA	 levels	 in	 both	 the	 two	 different	starvation	condition,	when	compared	to	the	untreated	cells	(Fig.	10).		
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Fig.	 10	Upregulation	 of	 filopodia	 genes	 upon	 HBSS	 and	 amino	 acid	
starvation	qRT-PCR	analysis	performed	on	IRSp53	and	EPS8	in	starvation	condition.	The	cells	starved	with	HBSS/Hepes	10µM	were	collected	after	6h;		The	 cells	 starved	with	RPMI	without	 amino	acid	were	 collected	after	6h.	RAGD,	 Mucolipin1,	 NEU1	 are	 known	 TFEB	 gene	 target	 and	 are	 used	 as	positive	control.			
4.4	TFEB	depletion	causes	a	decrease	in	mRNA	level	of	EPS8	
and	IRSp53	genes	in	HeLa	cell		To	confirm	that	the	increase	of	IRSp53	and	EPS8	mRNA	levels,	in	starvation	 condition	 was	 due	 to	 the	 TFEB/TFE3	 activation,	 I	decided	 to	 silence	 these	 two	genes	 in	HeLa	cells	 and	perform	a	qRT	 PCR	 experiment	 on	mRNA	 extracted	 by	 control	 and	 TFEB	and	TFE3	 silenced	 cells,	 in	 normal	 nutrient	 condition	 and	 after	nutrient	deprivation	(starvation	condition).	As	 expected,	 in	 control	 cells	 after	 HBSS	 and	 amino	 acid	starvation	treatments	I	could	observe	an	increase	in	IRSp53	and	
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EPS8	 mRNA	 level	 (Fig.	 10).	 This	 increase	 was	 instead,	undetectable	 in	 TFEB/TFE3	KD	 cells	 after	HBSS	 starvation	 and	amino	acid	starvation	treatment	(Fig.	11).		
	
Fig.	11	Filopodia	genes	expression	in	KD	TFEB-TFE3	HeLa	cells		qRT-PCR	 analysis	 performed	 on	 IRSp53	 and	 EPS8	 in	 fed	 and	 starvation	condition	 after	 72h	 transfection	 with	 siRNA	 TFEB/TFE3.	 The	 cells	 starved	with	HBSS/Hepes	10mM	were	collected	after	6h;	The	cells	starved	with	RPMI	without	 amino	 acid	 were	 collected	 after	 6h;	 RAGD,	 Mucolipin1,	 NEU1	 are	known	TFEB	gene	target	and	are	used	as	positive	control.			These	qRT-PCR	results	 indicate	that	 IRSp53	and	EPS8	show	the	same	behaviour	of	the	canonical	TFEB/TFE3	target	genes,	which	
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upregulation	is	impaired	in	TFEB/TFE3	KD	cells	after	starvation	(Fig.	11).		Collectively	these	data	strongly	support	the	idea	that	IRSp53	and	EPS8	 can	 be	 potentially	 target	 genes	 of	 TFEB	 and	 TFE3,	suggesting	a	role	of	these	two	transcriptions	factor	in	regulating	filopodia	formation.					
4.5	TFEB	overexpression	causes	an	increase	in	protein	level	
of	EPS8	and	IRSp53	in	HeLa	cell		In	 order	 to	 establish	 a	 direct	 correlation	 between	 mRNA	 and	protein	levels	of	EPS8	and	IRSp53	in	a	TFEB-dependent	fashion,	I	decided	to	perform	western	blot	(WB)	experiments	in	HeLa	cells	overexpressing	 the	 TFEB-wt,	 TFEB	 S142/211A	 and	 TFE3-wt	isoforms.	 After	 48h	 of	 transfection,	 I	 collected	 the	 protein	samples	 and	 I	 analyzed	 them	 with	 specific	 antibodies	 against	EPS8	 and	 IRSp53.	 As	 showed	 in	 Fig.	 12,	 I	 could	 observe	 an	increase	 of	 IRSp53	 (second	 lane)	 and	 EPS8	 (first	 lane)	 protein	levels	 in	 cells	 transfected	 with	 wt-TFEB	 and	 S142/211A-TFEB,	respectively,	while	the	increased	level	of	protein	in	the	condition	of	 TFE3	 overexpression	 was	 observed	 only	 for	 the	 IRSp53	protein.	 The	 experiments	 were	 performed	 in	 triplicate	 and	statistically	validated	(Fig12,	right	panel).		
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Fig.	12	Protein	levels	of		EPS8,	IRSp53	in	overexpression	condition	HeLa	
cells	Immunoblot	 analyses	 performed	 on	 wt-TFEB,	 S142/211A-TFEB,	 wt-TFE3	transfected	 cells	 to	 evaluate	 the	 protein	 expression	 of	 filopodia	 network	genes.	 Graphs	 represent	 the	 densitometry	 quantification	 of	 Western	 blot	bands.	Values	are	normalized	to	actin,	and	are	shown	as	an	average	(±	SEM)	(*	P	<0.05,	**	P	<	0.01,	***	P	<	0.001,	two-sided,	Student’s	t-test).		Moreover,	 to	 follow	 the	 regulation	of	 this	protein	 in	 absence	of	TFEB	 and	 TFE3,	 I	 performed	 a	 WB	 experiment	 in	 HeLa	 cells	depleted	by	siRNA	of	TFEB	and	TFEB/TFE3.	As	shown	in	Fig.	13,	also	 in	 these	 experimental	 conditions	 I	 could	 detect	 a	 strong	decrease	 of	 the	 EPS8	 protein	 levels	 in	 absence	 of	 TFEB	 or	
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TFEB/TFE3,	while	the	IRSp53	protein	levels	remain	stable	in	all	the	experimental	conditions	(Fig.	13).		 					
	
	
Fig.	13	Protein	levels	of	EPS8,	IRSp53	in	HeLa	cells	TFEB	KD	Immunoblot	 analyses	 performed	 on	 starved	 cells	 to	 evaluate	 the	 protein	expression	of	 filopodia	network	genes.	The	cells	 starved	with	HBSS/Hepes	10µM	were	collected	after	6h;	The	cells	 starved	with	RPMI	without	amino	acids	 were	 collected	 after	 6h;	 Graphs	 represent	 the	 densitometry	quantification	of	Western	blot	bands.	Values	are	normalized	to	actin,	and	are	shown	 as	 an	 average	 (±	 SEM)	 (*	 P	 <0.05,	 **	 P	 <	 0.01,	 ***	 P	 <	 0.001,	 two-sided,	Student’s	t-test).			This	 result	 suggests	 that	 the	 increase	 of	mRNA	 level	 of	 IRSp53	and	EPS8	in	TFEB	overexpressing	conditions	is	closely	linked	to	the	increase	of	IRSp53	and	EPS8	protein	levels.	Instead,	while	EPS8	protein	level	decrease	in	absence	of	TFEB	or	TFEB	 and	 TFE3,	 the	 IRSp53	 protein	 level	 seems	 to	 be	 more	
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stable	 in	 the	same	experimental	conditions,	suggesting	 that	 this	two	proteins	could	be	differently	regulated.				
4.6	 ChIP	 analysis	 of	 TFEB	 binding	 sites	 on	 filopodia	
promoters	 in	 HeLa	 TFEB	 overexpressing	 cells	 reveals	 a	
direct	regulation	of	TFEB	on	EPS8	
	As	 showed	 in	 Table	 2,	 the	 bioinformatics	 analysis	 of	 the	 genes	involved	 in	 filopodia	 network,	 the	 IRSp53	 gene	 promoter	presents	three	different,	non-canonical,	CLEAR	binding	sites:	one	located	at	-489	bp	(GTGCCA),	the	second	one	located	at	-468	bp	(CACGCG)	and	the	last	one	is	located	after	the	transcription	start	point	and	at	+72	bp	after	+1	(Fig.	14).	The	 EPS8	 gene	 promoter	 shows	 instead	 one	 canonical	 CLEAR	binding	site	located	at	-748	bp	(Fig.	14).		
	
Fig.	14	Predicted	CLEAR	binding	sites	in	IRSp53	and	EPS8	genes	Schematic	representation	of	IRSp53	and	EPS8	promoters,	and	of	the	CLEAR	binding	sites	present	inside		
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Since	 the	 previous	 data	 strongly	 suggest	 a	 correlation	 between	the	TFEB	and	TFE3	activation	and	the	regulation	of	the	EPS8	and	IRSp53	 genes,	 I	 performed	 experiments	 of	 Chromatin	Immunoprecipitation	 (ChIP)	 analysis	 in	 order	 to	 evaluate	 a	direct	binding	of	TFEB	on	the	IRSp53	and	EPS8	promoters.	To	 perform	 this	 experiment	 I	 used	 a	 stable	 cell	 line	overexpressing	TFEB	fuse	with	a	FLAG	tag.	To	induce	TFEB-FLAG	activation	I	treated	the	cells	with	RPMI	without	amino	acids.	To	 immunoprecipitate,	 TFEB-FLAG	 antibody	 against	 FLAG	 was	used.		Coimmunoprecipitated	 samples	 were	 purified	 and	 analyzed	 by	qRT-PCR.	The	results	were	analyzed	in	Fold	Change	of	the	target	genes,	 IRSp53	 and	 EPS8,	 in	 starved	 condition	 compared	 to	 the	fed	 condition.	 ChIP	 analysis	 showed	 an	 enrichment	 of	 EPS8	 in	HeLa	 starved	 cells	 compared	 to	 untreated	 cells.	 This	 data	 is	consistent	and	significant	(Fig.	15).			Surprisingly,	 I	 could	 not	 find	 any	 enrichment	 for	 the	 IRSp53,	suggesting	 that	 this	 gene,	 even	 if	 its	 expression	 seems	 to	 be	regulated	 in	 the	 condition	 of	 TFEB	 overexpressing	 and	 during	starvation,	is	not	a	direct	target	of	TFEB	(Fig.	15).	
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Fig.15	ChIP	analysis	on	predicted	CLEAR	binding	sites	on	filopodia	genes	The	graph	 represents	 the	qPCR	analysis	performed	on	ChIP	experiments	on	EPS8	 and	 IRSp53	 on	 a	 stable	 clone	 TFEB	 overexpressing	 cells	 starved	 by	RPMI	without	amino	acids	then	untreated	cell.		The	results	are	expressed	in	terms	of	Fold	Change.	MUCOLIPIN1	 represents	 the	 positive	 control;	 RPL30	 represent	 the	 negative	control.		On	 the	 other	 hand,	 ChIP	 assay	 experiments	 revealed	 that	 only	EPS8	is	a	direct	TFEB	transcriptional	target;	since	TFEB	is	able	to	recognize	and	bind	the	CLEAR	binding	site	present	on	the	EPS8	promoter.	 In	 turn,	 EPS8	 overexpression	 is	 able	 to	 bind	 IRSp53,	and	together,	they	play	a	fundamental	role	in	filopodia	formation	and	elongation.				
4.7	 TFEB	 and	 TFE3	 overexpression	 induce	 filopodia	
formation	in	HeLa	cell	
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	The	drastic	change	 in	cell	 shape	after	TFEB	overexpression,	 the	increased	ability	of	these	cells	to	migrate,	and	the	ability	of	TFEB	to	directly	regulate	the	EPS8	gene,	a	master	regulator	of	filopodia	induction,	strongly	suggest	that	TFEB	could	play	the	main	role	in	filopodia	formation.	In	order	to	statistically	confirm	the	effect	on	filopodia	increase	upon	TFEB	and	TFE3	activation,	I	performed	a	quantitative	 analysis	 of	 immunofluorescence	experiments	using	ImageJ	 software	 in	 order	 to	 count	 filopodia	 in	 different	experimental	 condition.	 HeLa	 cells	 overexpressing	 wt-TFEB,	S142-211A-TFEB	 and	 wt-TFE3	 using	 were	 stained	 with	phalloidin,	an	F-actin	probe	fluorescent	dye,	used	to	mark	F-actin	and	MYOX	antibody	that	recognizes	and	marks	the	final	point	of	filopodia	tips.		In	 normal	 nutrient	 condition,	 the	 cytoskeleton	 appears	 very	smooth	 in	 some	 areas	 without	 any	 protrusions	 or	 with	 few	filopodia,	marked	by	MYOX	(Fig.	16A).		
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Fig.	 16	 Overexpression	 of	 WT-TFEB,	 S142/211A-TFEB	 and	 wt-TFE3	 in	
HeLa	cells	induce	an	increase	of		MYOX	tips		Fluorescence	 analysis	 of	 TFEB	 and	 MIOX	 in	 untransfected	 cells	 (A),	 the	 cell	transfected	with	wt-TFEB	(B),	 S142/211A-TFEB	(C)	and	wt-TFE3	 (D).	 In	blue	DAPI	 (4',6'-diamidino-2-phenylindole	 staining),	 in	 green	 EGFP	 fused	with	 the	two	 TFEB	 isoforms	 and	with	 TFE3.	 In	 red:	 MYOX	 antibody	 staining.	 In	 grey:	phalloidin	dye	against	actin	cytoskeleton.	E.	The	Number	of	 filopodia	 in	untransfected	cell,	 the	cell	 transfected	with	wt-TFEB,	 S142/211A-TFEB	 and	wt-TFE3.	 The	 count	was	 obtained	 analyzing	 the	same	number	of	 images	using	Cell	Counter	 the	plugin	of	 ImageJ	program	and	was	normalized	to	untransfected	cells	(E).	The	values	are	shown	as	an	average	(±	SEM)	(*	P	<0.05,	**	P	<	0.01,	***	P	<	0.001,	two-sided,	Student’s	t-test).		As	shown	in	Fig.16,	since	the	wt-TFEB	expression	levels	are	high,	TFEB	 translocates	 into	 the	 nucleus,	 where	 it	 can	 activate	filopodia	 genes.	 In	 these	 conditions,	 I	 could	 appreciate	 an	increase	in	filopodia	number	(Fig.16	A-E).	As	 expected,	 in	 cells	 transfected	 with	 S142/211A-TFEB,	 the	constitutive	active	isoform,	I	could	observe	the	same	phenotype	(Fig.	16C-E),	as	well	as,	in	cells	transfected	with	TFE3	I	was	able	to	 count	 more	 filopodia	 when	 compared	 to	 the	 untransfected	cells	(Fig.	16D-E).	Using	ImageJ	software	I	could	count	the	number	of	filopodia	per	cell.	The	results	are	reported	in	Fig	16E.			I	found	that	the	filopodia	number	in	the	cells	transfected	with	the	wt-TFEB	or	the	S142/211A-TFEB	was	4	and	5	times	higher	than	the	 number	 counted	 in	 normal	 nutrient	 condition,	 respectively.	
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The	 same	 results	 were	 obtained	 counting	 filopodia	 in	 cells	transfected	with	wt-TFE3.		
4.8	TFEB	and	TFE3	activation	regulates	 filopodia	formation	
in	HeLa	cell		In	 order	 to	 establish	 the	 role	 of	 TFEB	 and	 TFE3	 in	 regulating	filopodia	 formation,	 I	 also	 performed	 experiments	 of	immunofluorescence	 with	 MYOX,	 in	 nutrient	 deprivation	condition	 (starvation)	 to	 induce	 TFEB	 and	 TFE3	 activation.	 In	starvation	 condition,	 after	 treatment	with	HBSS/Hepes	 10µM,	 I	could	 detect	 a	 strong	 increase	 in	 filopodia	 number	 marked	 by	MYOX,	if	compared	with	the	untreated	cell	(Fig.	17B,	A).		I	could	also	observe	a	more	dramatic	effect	on	filopodia	number	increase	 after	 treatment	 with	 RPMI	 without	 amino	 acids	 (Fig.	17C).		To	confirm	that	the	filopodia	induction	was	directly	regulated	by	TFEB	and	TFE3	activation,	I	performed	the	same	experiments	on	cells	TFEB	and/	or	TFE3	depleted.			In	 normal	 nutrient	 condition,	 TFEB	 depleted	 cells	 appears	drastically	 different	 compared	 to	 control	 cells,	 showing	 a	 total	absence	of	filopodia	(Fig.	17D).		The	presence	of	 filopodia	was	 then	 investigated	 in	 the	cell	with	TFEB	depleted	 but	 in	 starvation	 condition.	 In	 absence	 of	 TFEB,	under	 the	 starvation	 condition,	 cells	 are	 not	 able	 to	 induce	filopodia	 (Fig.	 17E).	 I	 could	 observe	 the	 same	 phenotype	 in
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condition	 of	 starvation	 performed	 using	 amino	 acids	 depletion	(Fig.	17F).		Moreover,	 I	 could	 observe	 the	 absence	 of	 filopodia	 in	 cells	depleted	 of	 both	 TFEB	 and	 TFE3	 under	 normal	 nutrient	condition	(Fig.	17G)	and	starvation	condition	(Fig.	17H,	I).	These	results	 confirm	 that	 the	 increase	of	 filopodia	number,	observed	in	starvation	condition,	was	due	to	the	TFEB	and	TFE3	activation.		The	images	have	been	quantified	and	statistically	validated	by	T-test	Fig.	17	L.	
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Fig.	 17	 TFEB	 nuclear	 translocation	 upon	 HBSS	 and	 amino	 acids	
starvation	in	HeLa	cells	induces	an	increase	of	MYOX	marked	tips;	
The	 absence	 of	 TFEB	 and	 TFEB/TFE3	 together,	 upon	 HBSS	 and	
amino	 acids	 starvation	 in	 HeLa	 cells	 causes	 a	 decrease	 of	MYOX	
marked	tips	Fluorescence	 analysis	 of	 wt	 fed	 cells	 (line	 A),	 	 HeLa	wt	 starved	 cells	with	 HBSS/Hepes	 10mM	 (line	 B),	 	 HeLa	 wt	 starved	 cells	 with	 RPMI	without	 amino	 acids	 (line	 C),	 	 TFEB	 KD	 	 cells	 in	 normal	 nutrient	condition	(line	D),		TFEB	KD	starved	cells	with	HBSS/Hepes	10µM	(line	E),	 TFEB	 KD	 starved	 cells	 with	 RPMI	 without	 amino	 acids	 (line	 F),	TFEB/TFE3	 KD	 fed	 cells	 (line	 G),	 TFEB/TFE3	 KD	 starved	 cells	 with	HBSS/Hepes	 10µM	 (line	 H),	 TFEB/TFE3	 KD	 starved	 cells	 with	 RPMI	without	amino	acids	(line	I).	L.	Number	of	filopodia	per	cell	is	reported.	The	values	are	shown	as	an	average	(±	SEM)	(*	P	<0.05,	**	P	<	0.01,	***	P	<	0.001,	two-sided,	Student’s	t-test).			To	 confirm	 that	 the	 mechanism,	 by	 which	 TFEB	 regulates	 the	formation	of	 filopodia	after	starvation,	 is	 through	the	activation	
L.	
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of	 EPS8	 and	 IRSp53,	 I	 performed	 immunofluorescence	experiments	of	MYOX	and	F-actin	in	cells	depleted	of	IRSp53	and	EPS8.	 As	 expected,	 after	 starvation	 by	 HBSS/Hepes	 10µM	 (Fig.	18B)	and	RPMI	without	amino	acids	(Fig.18C),	 in	HeLa	wt	cells,	TFEB	 migrates	 into	 the	 nucleus	 and	 the	 cells	 shown	 more	filopodia	 compared	 to	 untreated	 cells	 (Fig.	 18A,	 B,	 C).	 In	IRSp53/EPS8	 KD	 cells,	 after	 HBSS/Hepes	 10µM	 (Fig.	 18D)	 and	RPMI	without	 amino	 acids	 (Fig.18E)	 starvation,	 although	 TFEB	migrates	 into	 the	 nucleus,	 the	 cells	 are	 not	 more	 able	 to	 form	filopodia	and	the	cytoskeleton	appears	very	rarefied	and	cloudy.		
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Fig.	 18	 The	 absence	 of	 IRSp53	 and	 EPS8	 prevents	 the	 filopodia	
formation	under	starvation	treatments	in	HeLa	cells		Fluorescence	 analysis	 of	 HeLa	 wt	 fed	 cells	 (line	 A),	 HeLa	 wt	 starved	cells	with	HBSS/Hepes	10µM	(line	B),	HeLa	wt	starved	cells	with	RPMI	without	 amino	 acids	 (line	 C),	 IRSp53/EPS8	 KD	 fed	 cells	 (line	 D),		IRSp53/EPS8	 KD	 starved	 cells	 with	 HBSS/Hepes	 10µM	 (line	 E),	IRSp53/EPS8	KD	starved	cells	with	RPMI	without	amino	acids	(line	F).	In	 blue	 DAPI:	 4',6'-diamidino-2-phenylindole	 staining;	 In	 red:	 TFEB	antibody	 against	 the	 endogenous	 protein.	 In	 grey:	 phalloidin	 dye	against	actin	cytoskeleton.			
4.9	 Melanoma	 Cell	 line	 shows	 an	 increase	 in	 mRNA	 and	
protein	levels	of	IRSp53	and	EPS8	
	IRSp53/EPS8	 complex	 plays	 an	 important	 role	 in	 the	 positive	regulation	of	cancer	cell	motility	and	 invasiveness	 in	metastatic	tumor	 cell	 line24.	 These	 genes	 are,	 indeed,	 overexpressed	 in	
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tumor	 cell	 line.	 According	 to	 my	 results,	 this	 overexpression	could	be	due	to	an	upregulation	of	TFEB	and	TFE3.		To	test	this	hypothesis	I	decided	to	investigate	the	level	of	EPS8	and	 IRSP53	 in	 melanoma	 cell	 line,	 in	 particular,	 I	 choose	 the	501Mel	cells,	a	specific	cell	 line25,	associated	with	high	 levels	of	MITF,	 another	 member	 of	 the	 MiT/TFE	 family.	 By	 qRT	experiments	 I	 could	 observe	 that	 the	 IRSp53	 and	 EPS8	transcription	levels	in	501Mel	are	upregulated	at	about	2	and	2.5	times,	 compared	 to	 control	 cell	 line	 P375A	 (Fig.	 19).	 More	important,	 in	 the	 same	 cell	 line	 but	 depleted	 of	 MITF	 or	TFEB/TFE3,	 I	 could	 observe	 a	 reduction	 of	 the	 transcription	levels	of	 IRSp53	and	EPS8	when	compared	to	control	cells	 (Fig.	19).		
	
Fig.	19	Upregulation	of	filopodia	genes	in	Melanoma	cells	
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RT-PCR	 analysis	 performed	 on	 IRSp53,	 EPS8	 and	 MYOX	 to	evaluate	 the	 RNA	 levels	 in	 501Mel	 cell	 line	 than	 to	 CTRL	 cells,	MITF	KD	501Mel	cells	and	TFEB/TFE3	KD	501Mel	cells.		The	cells	were	collected	after	72h	post-transfection.			As	 expected,	 IRSp53	 and	 EPS8	 protein	 levels	 have	 the	 same	trend.	In	501Mel,	 IRSp53	and	EPS8	protein	 level	 increase	of	1.5	times,	for	both,	compared	to	control	cells	(Fig.	20).	A	reduction	of	IRSp53	was	also	observed	in	cell	depleted	of	MITF	or	 TEFB	 and	 TFE3	 (Fig.	 20).	 Western	 blot	 experiments	 were	performed	in	triplicate	and	statistically	validated.		
	
Fig.	20	Protein	levels	of	EPS8,	IRSp53	in	501Mel	cells	
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Immunoblot	 analyses	 performed	 on	 IRSp53	 and	 EPS8	 to	 evaluate	 the	protein	levels	in	501Mel	cell	line,	MITF	KD	501Mel	cells	and	TFEB/TFE3	KD	501Mel	cells.		The	cells	were	collected	after	72h	post-transfection.	Data	are	shown	as	the	average	 (±	SEM)	of	 three	different	experiments	and	values	are	normalized	to	 the	 untransfected	 cells	 (*	P	<0.05,	 **	P	<	0.01,	 ***	P	<	0.001,	 two-sided	Student’s	t-test).				
4.10	Filopodia	number	is	increased	in	Melanoma	cell	line		I	decided	to	analyze	the	presence	of	filopodia	in	501-Mel	cell	line.		To	this	end,	immunofluorescence	experiments	were	analyzed	by	imageJ	 software	 in	 order	 to	 count	 filopodia	 marked	 by	 MYOX	antibody	in	501-Mel	and	in	control	cells	(P375A).	Results	 are	 showed	 in	Fig.	 21,	 filopodia	number	 is	 increased	 in	501Mel	 cells	 compared	 to	 control	 cells	 (P375A),	 in	 normal	nutrient	condition;	while	after	depletion	of	MITF	or	TFEB/TFE3,	the	 filopodia	 phenotype	 was	 totally	 rescued	 and	 the	 501-Mel	cells	became	more	similar	to	the	control	cells	(Fig.	21).			
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Fig.	 21	Upregulation	of	MITF	 in	Melanoma	 cells	 induces	 an	 increase	of	
MYOX	tips		Fluorescence	 analysis	 CTRL	 (line	A),	 501Mel	 (line	B),	 and	MITF	KD	501Mel	cells	 (line	 C),	 TFEB/TFE3	 KD	 501Mel	 cells	 (line	 D);	 In	 blue	 DAPI:	 4',6'-diamidino-2-phenylindole	 staining;	 In	 red:	 MYOX	 antibody	 against	 the	protein.	In	grey:	phalloidin	dye	against	actin	cytoskeleton.	Values		graph	are	shown	as	an	average	(±	SEM)	(*	P	<0.05,	**	P	<	0.01,	***	P	<	0.001,	two-sided,	Student’s	t	test).			
4.11	TFEB	overexpression	in	HeLa	stable	cell	 line	increases	
the	invasiveness	ratio	of	the	cells		All	the	data	produced	in	this	thesis	work,	demonstrate	that	TFEB	and	 TFE3	 have	 a	 key	 role	 in	 filopodia	 formation,	 regulating	indirectly	 or	 directly	 two	 genes	 involved	 in	 filopodia	 network,	IRSp53	and	EPS8.		The	 abundance	 of	 filopodia	 at	 the	 leading	 edge	 of	 the	 cells	 is	considered	as	 a	 characteristic	 of	 invasiveness	 in	 the	 cancer	 cell	and,	moreover,	filopodia	are	directly	connected	to	cell	migration	because	 all	 components	 involved	 in	 filopodia	 formation	 are	fundamental	to	cell	motility.		For	this	reason,	I	decided	to	investigate	if	TFEB	and	TFE3	could	have	a	role	in	increasing	cell	invasiveness.	Invasion	through	the	extracellular	matrix	(ECM)	is	an	important	step	 in	 tumor	 metastasis.	 Cancer	 cells	 initiate	 invasion	 by	adhering	and	spreading	along	 the	blood	vessel	wall.	Proteolytic	enzymes,	 such	 as	 MMP	 collagenases,	 dissolve	 tiny	 holes	 in	 the	
	
	
	 83	
sheath-like	 covering	 surrounding	 the	 blood	 vessels	 to	 allow	cancer	cells	to	invade114,115.	I	 decided	 to	 use	 the	 CHEMICON	 cell	 invasion	 assay	 kit	 that	 is	ideal	for	evaluation	of	invasive	tumor	cells.		I	 evaluated	 the	 invasive	 ratio	 of	 TFEB	 overexpressing	 HeLa	stable	clone	(CF7)	compared	to	HeLa	control	cell	line.		48h	after	plating	the	cells,	TFEB	overexpressing	cells	are	double	in	the	lower	part	of	the	chamber	membrane	than	to	control	cell	(Fig.	 22),	 indicating	 that	 in	 the	 same	 conditions,	 the	 cells	overexpressing	TFEB	have	a	double	invasive	power	compared	to	control	cells.											HeLa	wt																																																																				HeLa	CF7_TFEBovx	
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Fig.	 22	TFEB	 overexpression	 increases	 the	 ability	 of	 invasiveness	 of	 the	
cells	Invasion	 assay	 on	 HeLa	wt	 cells	 and	 HeLa	 stable	 clone	 TFEB	 overexpressing	(CF7)	cell;	The	cells	are	analyzed	after	48h	plating	in	the	same	specific	chamber	and	are	photographed	by	APOTOME	microscope.	The	count	is	done	on	the	same	number	 of	 images,	 using	 ImageJ	 program,	 Cell	 Counter	 plugin,	 the	 values	 are	shown	as	an	average	(±	SEM)	(*	P	<0.05,	**	P	<	0.01,	***	P	<	0.001,	two-sided,	Student’s	t-test).		These	 results	 are	 in	 agreement	 with	 the	 wound-healing	 assay,	and	 strongly	 support	 a	 role	 of	 TFEB	 in	 contributing	 in	 cells	migration	 and	 invasiveness	 regulating	 the	 formation	 and	elongation	of	 filopodia,	 through	the	transcriptional	activation	of	EPS8	and	IRSp53.			
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Chapter	5	
Discussion		
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TFEB	 has	 been	 shown	 to	 be	 a	 master	 regulator	 of	 lysosomal	biogenesis,	function	and	autophagy,	via	transcriptional	control	of	gene	expression.	In	the	last	years,	several	studies	have	elucidated	the	mechanism	 of	 TFEB	 regulation,	 showing	 the	 existence	 of	 a	lysosome-to-nucleus	 signaling	 mechanism	 that	 senses	environmental	 changes	 and	 regulates	 lysosomal	 function	 via	TFEB	 phosphorylation.	 Moreover,	 TFEB	 roles	 have	 been	associated	 in	 tumorigenesis	 in	 different	 tissues,	 although	 the	specific	 genes	 involved	and	 the	associated	mechanisms	are	 still	unclear.		Filopodia	are	described	as	 the	sensor	of	 the	cell's	 surroundings	and	have	been	demonstrated	to	be	 important	 in	cell	motility.	 In	turn,	cell	motility	is	involved	at	every	stage	of	tumorigenesis	and	contributes	to	primary	tumour	growth,	cancer	cell	dissemination	and	metastasis	formation.	The	discoveries	of	TFEB,	as	an	important	player	in	the	formation	and	 regulation	 of	 filopodia,	 could	 open	 a	 new	 view	 by	 which	TFEB,	 through	 a	 transcriptional	 regulatory	mechanism	 enables	cellular	 adaptation	 to	 external	 cues	 and	 in	 physiopathological	condition	could	contributes	not	only	to	the	energetic	metabolism	of	cancer	cells,	but	also	to	a	mechanistic	point	of	view	increasing	cell	motility.	From	 these	 studies,	 I	 demonstrate	 that	 two	major	 genes,	 EPS8	and	 IRSp53,	 involved	 in	 filopodia	 formation,	 are	 regulated	 by	TFEB	and	TFE3.		
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I	revealed	that	in	the	condition	of	TFEB	and	TFE3	overexpression	or	 overactivation	 the	 number	 of	 filopodia	 increases,	 while	 in	 a	TFEB/TFE3	 KD	 context	 they	 are	 totally	 absent.	 The	 increased	number	of	 filopodia	 correlates	with	 the	 increased	 level	of	EPS8	and	IRSP53	in	TFEB/TFE3	overexpression	condition	as	well	as	in	the	 condition	 of	 TFEB/TFE3	 activation	 under	 nutrient	deprivation.	 Moreover,	 the	 upregulation	 of	 these	 genes	 upon	nutrient	 deprivation	disappears	 in	 the	 condition	 of	 TFEB/TFE3	KD,	 indicating	 that	 the	regulation	of	 these	genes	 is	mediated	by	TFEB	 and	 TFE3.	 As	 expected	 depletion	 of	 EPS8	 and	 IRSP53,	drastically	reduce	the	number	of	filopodia	in	HeLa	cell	line	under	nutrient	 deprivation.	 ChiP	 data	 revealed	 that	 only	 EPS8	 is	 a	direct	 target	 of	 TFEB,	 suggesting	 that	 the	 regulation	 of	 IRSp53	could	 be	 due	 to	 an	 indirect	 effect	 on	 TFEB	 in	 regulating	 EPS8.	Indeed,	 it	 has	 been	 demonstrated	 that	 IRSp53	 is	 the	 principal	partner	 of	 EPS8	 in	 various	 cancer	 cell	 line	 and	 that	 the	IRSp53/EPS8	complex	occurs,	at	the	leading	edge	of	the	cells,	for	motility	and	invasiveness116.	To	show	the	relevance	of	the	TFEB/TFE3-EPS8	axis	I	decided	to	use	a	model	of	a	cancer	cell	with	 the	high	 level	of	 invasiveness.	Melanoma	cell	line	was	the	best	model	to	use,	since	the	presence	of	 high	 level	 of	 MITF	 at	 steady	 state	 that	 is	 required	 for	melanoma	 proliferation.	 In	 this	 cell	 the	 number	 of	 filopodia,	marked	by	MYOX	 increase	drastically,	as	well	as	 the	mRNA	and	protein	 levels	 of	 IRSp53	 and	 EPS8	 compared	 to	 a	 control	 cell.	Moreover,	 the	 increased	 number	 of	 filopodia	 was	 reduced	 in	
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absence	 of	MITF	 as	well	 as	 in	 the	 condition	 of	 TFEB	 and	 TFE3	depletion.	 Taking	 together	 these	 results,	 strongly	 suggest	 that	TFE	 transcription	 factors	 play	 a	 key	 role	 in	 the	 regulation	 of	filopodia	formation.		Filopodia	and	filopodia	proteins	give	a	very	critical	contribution	to	 cancer	 metastasis,	 the	 understanding	 of	 the	pathophysiological	processes	underlying	 the	 role	of	 filopodia	 in	cancer	 could	 open	 a	 new	 attraction	 for	 therapeutic	 targets	 to	block	 cancer	 dissemination.	My	data	 support	 the	new	 idea	 that	activation	of	TFEB	could	contribute	 to	 this	mechanism	and	 that	acting	on	TFEB	 regulation	 could	 represent	 an	effective	 strategy	to	 rescue	 pathological	 conditions	 of	 metastases	 movement	 in	cancer.						
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